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This study aims to provide insights into the application of next generation sequencing for the 
study of hospital-acquired staphylococcal infections. Staphylococcus aureus is a gram-
positive, commensal species of bacteria that are a common constituent of the human 
microbiome. However, many of the strains of this opportunistic pathogen, the causative 
agent of a wide range of infections, have now acquired resistance to many frequently used 
antibiotics. At its worst, the threat of antimicrobial resistance could result in increased rates 
of post-surgical mortality for even routine surgical procedures and, generally, make clinical 
facilities potential epicentres for infection outbreaks. 
 With that in mind, this body of work will focus largely on methicillin resistant S. aureus 
(MRSA), given its relevance in clinical environments currently.  A metagenomic approach was 
used in an attempt to monitor the transmission of microbial pathogens upon the relocation of 
a paediatric burns unit from one site to another, however an unfortunate technical oversight 
prevented with project from being completed.  
In the study of an epidemic strain ST228, an attempt was also made at establishing any causal 
relationships between bacterial phenotypes and their ability to disseminate to the scale of an 
outbreak, however no inferences could be gleaned from the study of biofilm formation, toxin 
production and phage susceptibility in select isolates from the ST228 cohort, warranting 
further study.  
Finally, a GWAS was carried out on a cohort of ST239 isolates for biofilm formation and 
protease activity. The protease GWAS identified potential associations with certain loci in the 
TW20 reference genome, however either the lack of sensitivity of the assay used or inherent 
differences between the proteolytic potential of ST239 and the USA300_FPR3757 strain that 
made up the available transposon mutant library meant that the dataset was ultimately 
inconclusive. Five genes (mecA, sgaT, ccrB, aap and hyp) were identified as potentially being 
associated to biofilm formation in ST239. Verification of these associations through 
complementation was unsuccessful. Ultimately, despite some technical issues, the analysis of 
whole genomic sequence data combined with the screening of a large collection of ST239 
isolates identified a handful of potentially novel effectors of biofilm formation that warrant 
additional characterization in the future  
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INTRODUCTION  
STAPHYLOCOCCUS AUREUS AND NOSOCOMIAL INFECTIONS 
 
The Burden of Nosocomial Infection 
Nosocomial infections, also known as hospital-acquired infections (HAIs), are a leading cause 
of patient death globally, with an estimated 4% of acute-care patients contracting at least one 
during admission in the US (Hassan Ahmed Khan, Ahmad and Mehboob, 2015). The 
developing world is hit hardest however, with the average number of nosocomial infections 
increasing to 40% (Hassan Ahmed Khan, Ahmad and Mehboob, 2015). Globally, this can in 
part be attributed to aging populations and, on average, larger hospitals, with central 
catheter insertion and long admission times being key risk factors for later infections (Lax and 
Gilbert, 2015). In addition to causing significant morbidity and mortality, nosocomial 
infections are estimated to cost US hospitals $4.5 billion dollars annually (Reed and 
Kemmerly, 2009). The infections causes by these pathogens vary widely, with some of the 
most frequent infection types including central line-associated bloodstream infections, 
catheter associated urinary tract infections and surgical site infections (Khan, Baig and 
Mehboob, 2017). A particular group of common nosocomial pathogens, the “ESKAPE 
pathogens” (Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species 
specifically), have the additional challenge of often being resistant to a number of commonly 
used antimicrobials (Boucher et al., 2009). This report will focus on one of the leading 
causative agents of HAIs, S. aureus. Annually, in the US alone, S. aureus is responsible for over 
20,000 deaths (Thomer et al., 2016) – costing more lives annually in the US than HIV/AIDS 
(Peschel and Otto, 2013) . 
Staphylococcus aureus 
Bacteria within the genus Staphylococcus are gram-positive, catalase-positive cocci that 
aggregate into characteristic grape-like clusters. This genus can be subdivided into 42 species, 
of which 10 can be subdivided into subspecies. Individual isolates within the species S. aureus 
can be further characterized and distinguished through multilocus sequence typing (MLST), 
where isolates are distinguished from one another through sequence variation of internal 
fragments of seven housekeeping genes. These sequence variations can then be assigned as 
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distinct alleles from which further clonal groups, known as clonal complexes (CCs) and 
sequence types (STs), can be formed (Enright et al., 2000).  
Bacteria in the genus Staphylococcus are largely 
opportunistic pathogens, with many acting as 
commensal bacteria on the skin of a host until an 
opportunity for sub-cutaneous invasion presents 
itself (such as via indwelling medical devices or the 
colonisation of a wound surface) (Ghebremedhin 
et al., 2008). This genus contains one of the most 
frequently isolated species of pathogens for 
clinical samples, Staphylococcus aureus 
(Kobayashi, Malachowa and DeLeo, 2015).  
S. aureus (Figure 1) is one of the most common bacterial pathogens worldwide, responsible 
for a myriad of infections (Otto, 2013). While around 30% of the population are intermittently 
colonised by the bacteria, and 20% of the population permanently colonised (Otto, 2010), this 
usually benign constituent of the human microbiome is also the causative agent of numerous 
skin and soft tissue infections, as well as bacteremia, infective endocarditis and pulmonary 
infections. As such, this pathogen is of global importance as a leading cause of morbidity and 
mortality, particularly in clinical setting.  
Methicillin-resistant S. aureus 
MRSA has been a significant burden to healthcare providers for many years, with the first 
incidence of nosocomial MRSA infections occurring in 1985 (Farr et al., 2001). Following the 
sudden appearance of this pathogen in the media and public consciousness, various infection 
control management strategies were implemented in the UK in the early twentieth century to 
reduce the transmission frequency of this high profile ‘superbug’. In 2013, a high-profile 
statement from Professor Dame Sally Davies (Chief Medical Officer for England) described 
microbial antibiotic resistance to be ‘as big a risk as terrorism’, stating that routine operations 
could become life-threatening in as little as 20 years’ time. However, despite media attention 
having somewhat moved away from MRSA and other nosocomial infections, the emergence 
of epidemic strains of these common nosocomial pathogens is a reoccurring challenge to 
modern clinical microbiology. Active surveillance screening has been used in various countries 
Figure 1- An SEM image of the 
characteristic grape-like clusters of S. 
aureus (Janice Haney Carr, CDC) 
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as a means of preventing exogenous transmission of the pathogen, as increasing hand 
hygiene and contact isolation alone has previously been described as inadequate in 
controlling the spread of nosocomial pathogens. However, given that we’ve seen a 24.5% 
increase in MRSA cases of bacteremia since these reports were made mandatory, more still 
needs to be done (Thelwall et al., 2017). 
MRSA, as with any isolate of S. aureus, often causes relatively minor skin and soft tissue 
infections. Yet, when a breach exists within a potential hosts immune defenses, this 
opportunistic pathogen is given the opportunity to become a causative agent of a host of life-
threatening infections, including bacteraemia, pneumonia and endocarditis (Bamberger, 
2007). In the case of MRSA, resistance for widely used beta-lactam antibiotics is gained 
through the acquisition of the mobile genetic element (MGE) SCCmec and the well-
characterised mecA gene carried within it (Chongtrakool et al., 2006). Worryingly, 
vancomycin, a common choice of treatment for MRSA infections, may be also be rendered 
ineffective by the emergence of vancomycin resistance in S. aureus, which was first reported 
in 2002 (Chang et al., 2003). Despite the relatively recent gains made through the discovery of 
antibiotics, our species arms race against our natural pathogens is not as close-run as we 
might like to believe.  
Within this report, two STs of MRSA will be investigated further, ST228, otherwise known as 
the Southern Germany clone (Mick et al., 2010), and ST239, one of the most predominate 
clones of MRSA in nosocomial infections (Abimanyu, Murugesan and Krishnan, 2012). 
PATHOGENESIS IN S. AUREUS 
 
S. aureus and MRSA infections vary so significantly in part due to the number of genes 
involved in the intricate regulation of S. aureus pathogenesis, allowing for its rapid replication 
and dissemination to a range of sites. Potential disease manifestations including infective 
endocarditis, organ tissue abscesses and sepsis (Peschel and Otto, 2013) . Understanding the 
mode through which S. aureus exerts its pathogenicity is essential for improving our 
treatment of the many infections caused by it.  
Human skin is the first line of defense of the immune system: a layer of keratinocytes serving 
as a physical barrier to prevent the entry of invading bacterial pathogens into deeper layers of 
tissue. In instances where there has been a traumatic breach of this barrier, a complex cellular 
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response occurs to mobilise immune cells to the site of infection (Kobayashi, Malachowa and 
DeLeo, 2015). However, once that initial breach is made, whether the resulting infection is 
benign or life threatening depends, in part, on which virulence factors the strain possesses. 
Virulence factors, molecules that increase the likelihood of a pathogen causing disease, are 
often encoded on MGEs, which are able to then be transferred from one strain to another 
through horizontal gene transfer (Otto, 2014). 
The phenotypic plasticity of S. aureus makes this species particularly interesting to study, 
since the propensity of this pathogen for transferring virulence genes has given rise to the 
abundance of virulence factors these bacteria are able to employ. The expression of the vast 
set of genes that are responsible for exerting S. aureus virulence is highly regulated through 
the action of a variety of regulatory genes (Figure 2), the combined actions of which 













Figure 2 A schematic representation of the regulatory genes in S. aureus that interact 
to induce either upregulation or downregulation of adhesin (A), evasin (E) or toxicity 
(T) genes (Recker et al., 2017) 
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Together the differential expression of the arsenal of accessory genes that govern S aureus 
pathogenicity, government by the various proteins and RNA molecules that make up the S. 
aureus virulence regulatory network, produce strain-specific virulence profiles, with some 
strains being more invasive or toxic than others (Otto, 2014).  
One of the best characterized gene systems through which S. aureus pathogenicity is 
moderated is through the global regulator agr. This operon is a quorum-sensing system 
enabling cell-to-cell communication and is made up of divergent transcription units that 
comprises five separate agr genes that result in the production of RNAIII, an effector 
molecule for a number of downstream gene targets responsible for the production of 
colonisation and virulence factors (Novick, 2003) (Figure 3). The agr operon coordinates the 
differential expression of cell-surface adhesion proteins, exogenous toxins and evasin genes in 
response to cell population density – for example, when a bacterial population reaches 
around late exponential/early growth phase, adhesins are downregulated whilst toxins such 
as staphylokinase, hemolysins, protein A and toxin shock syndrome toxin-1 (TSST-1) are 
upregulated (Pragman and Schlievert, 2004) . The agr system is also responsible for epithelial 
cell invasion and apoptosis (Jeremy M. Yarwood and Schlievert, 2003). When agr is 
downregulated, S. aureus persists as a coloniser of the human epidermis and other surfaces 
Figure 3 The accessory gene regulator (agr) system in Staphylococcus (Jeremy M. 
Yarwood and Schlievert, 2003) 
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through the action of wall teichoic acid mediated adherence, and then the binding of 
microbial surface components recognizing matrix molecules (MSCRAMMs) to the mammalian 
extracellular matrix, allowing the pathogen to adhere to its host and, ultimately, colonise host 
tissues (Christopher et al., 1999). 
Another well-characterised regulator of S. aureus virulence factors is the staphylococcal 
accessory regulator (SarA), a DNA-binding protein expressed from three promotors that binds 
to both the P2 and P3 promoters of the agr system. However, sarA plays a role in regulating 
other virulence factors of its own, including downregulating protease activity, activating α-
hemolysin and staphylococcal enterotoxin B expression and binding to fibronectin-binding 
protein and staphylococcal enterotoxin C promotors (Pragman and Schlievert, 2004). 
These are just two of the most well-known regulators within the S. aureus genomes – a 
drastic simplification of the complexity of the interactions of the regulator genes involved in 
determining the expression levels of evasins, toxins and adhesins. They act in concert to 
determine a plethora of important, clinically relevant phenotypes.  
S. aureus virulence determinants 
A wealth of pathogenic determinants exists which, collectively, mediate S. aureus tissue 
colonization and tissue damage. Adhesins, for instance, facilitate the pathogens adherence to 
host cells and largely include a family of molecules called MSCRAMMs. MSCRAMMs include 
important molecules for cell surface attachment, including clumping factors and fibrinogen-
binding proteins (Spellberg and Daum, 2012). Meanwhile leukocidins such as Panto-Valentine 
leukocidin (PVL), an example of an evasin, interfere with the host’s immune system (Eap) 
(Spellberg and Daum, 2012). Additionally, a variety of toxins, molecular agents that directly 
harm the host, as well as biofilm production and resistance to antibiotics all work in concert 
to exert S. aureus pathogenicity. An overview of the various virulence factors in various 
infections can be seen in Figure 4.  
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Figure 4 The various virulence factors employed by S. aureus during infection (Spellberg and 
Daum, 2012) 
Staphylococcal toxins 
The broad range of staphylococcal toxins, which facilitate damage to host tissue during an 
infection, can be grouped into three distinct categories:  
1. Membrane-damaging or cytolytic toxins: these produce breaks in host cell 
membranes that lead to the efflux of vital metabolites and ultimately lyse the cell. 
These include α-toxin, which produced pores within the membranes of erythrocytes 
and several leukocytes (Otto, 2014). 
2. Toxins that inhibit the action of host cell receptors:  these include the staphylococcal 
enterotoxins, a class of superantigens responsible for disrupting intestinal function, 
and TSST, a superantigen which stimulates the release of numerous cytokines, 
including interleukin (IL) -1 and -2 and tumour necrosis factor (TNF) α (Otto, 2014). 
3. Secreted enzymes: through degrading host molecules, this class of toxin can interfere 
with host cell metabolism and signalling cascades. These include a class of enzymes 
known as proteases. S. aureus has the ability to synthesis and secrete 10 major 
proteases; aureolysin (aur), V8 (SspA) serine protease, staphopains A and B (ScpA and 
SspB respectively) and six separate serine-like SspA homologues (SplABC-DEF) (Kolar 
20 
et al., 2013). These proteases interact in an interdependent post-translational 
activation cascade to exert a variety of vital roles, including the modulation of surface 
adhesive molecules of the bacteria, resulting in a shift from an adhesive phenotype to 
an invasive one, disseminating the pathogen further (Shaw et al., 2004). A cascade of 
serine proteases specifically plays a role in coagulation through the enzymatic 
conversion of prothrombin to thrombin and the cleavage of fibrinogen into soluble 
fibrin (Friedrich et al., 2003).  In addition, the proteolytic activity of these enzymes 
have been attributed to serpin inactivation (a protein important in processes 
including coagulation and inflammatory immune responses), the degradation of 
various extracellular matrix components and prothrombin activation (another 
important protein in host coagulation)(Shaw et al., 2004), suggesting that the 
cumulative action of these proteolytic enzymes play active roles in both invasive 
phenotypes, dissemination and evasion of innate host immunity.  
Biofilm formation 
Staphylococci, along with many other genera of bacteria, can establish dynamic social 
agglomerations known as biofilms, in which multiple bacterial cells are encased within an 
extracellular polymeric substance (EPS). Biofilm formation is in many ways a more 
advantageous state than the planktonic, single-cell state of singular bacteria, particularly for 
colonisers of mammalian skin such as S. aureus, which not only protects bacteria from drastic 
environmental change or being washed off a surface, but also provides protection from 
innate host defense mechanisms and antibiotics (Thurlow et al., 2011). Although there is a 
certain degree of uncertainty and controversy surrounding what constitutes a biofilm, it is 
becoming increasingly evident that nosocomial bacterial infection commonly involves 
biofilms, particularly in cases involving the insertion of indwelling medical devices and wound 
infections (Archer et al., 2011). Within these bacterial aggregates, biofilm formation is 
modulated elegantly through the sophisticated quorum sensing agr operon (the 
aforementioned master-controller of the transcription of virulence factors) (J. M. Yarwood et 
al., 2004).  S. aureus biofilms are embedded within glycocalyx (a network of polysaccharide 
fibers that extend out from the cell wall), formed after the initial adhesion of S. aureus to a 
surface in the first step of biofilm development; attachment. This is facilitated through non-
covalent interactions between the surface-attached adhesins such as MSCRAMMs and host 
tissue/abiotic surfaces (Otto, 2008).  
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Following attachment, proliferation and maturation of the biofilm occurs. This involves the 
production of an extracellular matrix consisting of polysaccharide intracellular adhesins (PIAs), 
teichioc acids, environmental DNA (eDNA) and proteins with intricate channels formed to 
mediate the transfer to nutrients through the layers of the biofilm. Once the biofilm has 
developed sufficiently, clusters of the biofilm detach in order to be disseminated to distal 
locations within the host (Le et al., 2014) (Figure 3). 
 
Figure 3 The stages of biofilm development in S. aureus (Le et al., 2014) 
Bacteriophage-resistance 
Bacteriophages (shortened to phages hereafter), an entity even more abundant than bacteria, 
are bacterial viruses that need to infect a bacterial host in order to replicate, making them an 
interesting alternative therapeutic agent for infections caused by multidrug resistant bacteria 
(Sulakvelidze, Alavidze and Morris, 2001). The microflora of the human body is known to 
include an abundance of various bacteriophages, which are putatively regarded as important 
for maintaining the body’s regular microbial ecology (Clokie et al., 2011). Given their 
abundance, several pathogens, S. aureus included, have evolved resistance against lytic 
phage. However, a trade-off between this resistance and the production of other virulence 
determinants can occur (León and Bastías, 2015), thus making phage resistance an interesting 
phenotype to compare alongside toxin production and biofilm formation.  
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INFECTION CONTROL IN THE POST-GENOMIC ERA  
The advent of high throughput DNA sequencing technology has resulted in various paradigm 
shifts in classical microbiology: one of the many facets of the life sciences expanded during 
the genomic era. Conventional bacterial classifications based on bacterial colony morphology 
increasingly gave way to species identification through 16S ribosomal RNA sequencing. Since 
then, species and clonal variant identification has steadily improved, with whole-genome 
mapping steady increasing in resolution, owing to the dramatic improvement of both speed 
and affordability that modern sequencing methods have to offer. In the last few decades, the 
number of bacterial genomes fully sequenced has grown almost exponentially (Land et al., 
2015), and this trend is set to continue, with technologies such as hand-held sequencing 
platforms promising instantaneous sequencing already commercially available.  
In the case of infection and immunity, whole-genome sequencing (WGS) of pathogens within 
clinical samples is often used to provide insights into the genomic epidemiology of bacteria 
commonly responsible for nosocomial infections – a practice made easier by the fact that 
these samples are routinely collected already within clinical environments. Various clinical 
infection control initiatives exist to curb the likelihood of infecting new patients according to 
what is already known about how pathogens spread in clinical environments. For example, 
the hands of healthcare workers (HCWs) are routinely cited as one of the most common 
vehicles by which microorganisms are transmitted from one patient to another (Saloojee and 
Steenhoff, 2001). Additionally, other putative modes of transmission for common nosocomial 
pathogens include HCW clothing/personal items (such as stethoscopes and personal phones) 
and fomites in clinical environments including computer keyboards and medical devices (Lax 
and Gilbert, 2015). While poor infection control practices do increase the risk of nosocomial 
infection, good hygiene practices sadly are not enough to prevent microbial transmission 
from staff to patients. It is estimated that between 4-6% of healthcare workers in any one 
hospital harbour nosocomial pathogens on their skin, with the risk of carriage by healthcare 
workers elevated by comorbidities (such as recent urinary tract infections and cystic fibrosis), 
recent antibiotic use, previous work abroad and high work load (Albrich and Harbarth, 2008). 
That said, however, infections are by and large also transfected through either direct or in 
direct contact between patients, visitors and environmental sources (Boucher et al., 2009). 
Ultimately, our current knowledge of how to curb the spread of pathogens in healthcare 
environments needs to improve to provide efficient and reliable infection control strategies. 
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 This report presents a body of work exploring several approaches that utilise our recent 
advances in genomics: metagenomics, a “phenotype-first” approach to studying epidemics 
and genome-wide association studies (GWAS) as a tool for identifying novel candidate genes 
associated to clinically relevant phenotypes. 
Metagenomics 
Increasing our understanding of the intricate molecular processes occurring within 
populations of bacteria that are representative of clinical environments is of paramount 
importance. Effective infection control requires knowledge of the relationship between 
environmental contamination and incidence of patient infection, the elucidation of potential 
candidate genes involved in sudden incidences of hospital epidemics and new insights into 
unexplained changes in an infected patients morbidity.  
Our lack of a concrete understanding of the population dynamics of clinical pathogens can, in 
part, be attributed to studies carried out previously that focused on known pathogens and a 
reliance on microbial cultures. A strong argument can be made for the utility of metagenomic 
sequencing in the monitoring of microbial populations within clinical settings. Assessing the 
whole microbiome of an environmental sample offers a viable alternative to the ‘needle in a 
haystack’ approach to microbial epidemiology (via selecting for specific nosocomial pathogens 
of interest), which often fails to give a true picture of microbial diversity (Lax and Gilbert, 
2015). Such approaches have already been carried out in the development of a sequence-
based diagnosis tool for wound and post-surgical infection (Chan and Chan, 2013). Microbial 
metagenomic analysis of clinical environments are only beginning to emerge within the 
literature, with the first reported use of real-time metagenomic next-generation sequencing 
to influence infection control occurring in 2017 (Greninger et al., 2017).  
For clinical or environmental samples with relatively complex microbiomes, the faithful 
detection and identification of the species diversity within that sample can be difficult to 
ascertain using conventional sequencing methods, such as Sanger sequencing of specific 
pathogens individually (Nakamura et al., 2008). With newly developed next-generation DNA 
sequencers able to sequence over 100 megabases of DNA per run (Nakamura et al., 2008), 
shotgun metagenomics has emerged as a successful alternative to conventional sequencing. 
This method allows for the untargeted sequencing of all the genomes present in a sample, 
providing insights into the taxonomic composition of the microbial community whilst also 
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recovering whole genomic sequences. Metagenomic approaches to the study of a samples 
microbiome may therefore provide a more accurate impression of the full species diversity 
within a sample, including those that are frequently difficult to culture in laboratories (Quince 
et al., 2017). Shotgun metagenomics may be used to overcome a number of challenges to the 
field of clinical microbiology and, with time, could provide more accurate diagnoses and 
therapeutic strategies, informed by a comprehensive understanding of the genome of the 
causative agent, can be tailored to maximise the efficacy of any subsequent treatment.   
The first aim of this project was to survey any changes to the microbial burden of a burns unit 
caused by its relocation. The relocation of the Bristol Children’s burns unit in 2014 presented 
an exciting opportunity to employ metagenomics to studying changes to a wards microbial 
ecology when a clinical environment moves geographically. Chapter 1 details the collection of 
environmental samples from a children’s burns unit in Bristol (UK), a hospital used for 
casualties during World War II, to a larger unit within a newer hospital that was deep-cleaned 
before the move. From this, it was intended that various common nosocomial pathogens 
from a single environmental sample could be pooled and sequenced in tandem to illustrate 
the potential changes to transmission dynamics seen within a children’s burns unit and the 
effect that a ward relocation has on species diversity.  
Deriving molecular explanations for outbreaks from strain phenotyping 
In studies centered around community associated MRSA (CA-MRSA), the striking ability of this 
pathogen to evade host immunity so effectively and spread so easily has been attributed to 
either the action of PSMs or PVLs (Otto, 2012). However, in HA-MRSA (hospital-acquired 
MRSA) limited information currently exists regarding staphylococcal phenotypes that play a 
role in establishing an outbreak, which can result in instances where, despite adhering to 
common infections controls, outbreak can occur suddenly and dramatically. Lausanne 
University Hospital, for instance, saw an unexpected spike in infections caused by MRSA-
ST228 in 2008, after previous outbreaks of ST228 in 2001 and 2003 seemed to be mitigated 
by the infection control efforts of the hospital (Vogel et al., 2012). The second aim of this 
project, described in Chapter 2, was to explore why the 2008 outbreak occurred through a 
study of phenotypic differences in strains collected throughout all three outbreak periods. 
Given the unusual pattern of ST228 outbreaks seen at this hospital and the fact that previous 
genomic analysis of the isolates failed to explain the reasons for this outbreak, a few 
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phenotypes of interest were studied within ST228 isolates taken various years between 2000 
and 2009, with a view towards potentially correlating a given phenotype with high incidences 
of ST228 infections – a “phenotype-first” look at epidemics that may suggest that factors 
outside the genome (for instance, post-translational modifications) could be responsible for 
the outbreak periods observed. The subset of ST239 strains chosen from the Lausanne 
outbreak strain collection were tested for biofilm formation, susceptibility to lytic phage and 
δ -toxin and PSM production. 
Genome-wide association studies 
The advent of novel high-throughput genotyping makes genome-wide association studies 
(GWAS) an attractive approach to studying populations of pathogens within clinical 
environments. GWASs test large numbers of genetic variants (including whole genes, single 
nucleotide polymorphisms (SNPs) and insertions/deletions (INDELs) within a population for 
statistically significant associations to a certain phenotype (Read and Massey, 2014). This 
bottom-up approach to identifying the molecular basis of phenotypes begins with a specific 
phenotype of interest and associates any differences in phenotype within a population with 
particular loci in the pan-genome (Falush and Bowden, 2006). This technique, which was first 
employed as a way of extrapolating Mendelian principles to complex inherited disorders in 
humans (Visscher et al., 2012), has shown a comparatively muted level of interest within 
microbiology. This is in spite of the fact that, owing to the smaller genome of bacteria, the 
consensus base-calling accuracy is usually higher in bacterial GWAS, given that the average 
coverage of Illumina shotgun projects is rarely less than 20 (Read and Massey, 2014). The 
concept of correlating phenotype to the bacterial genome is not a new one; comparative 
genome hybridization (CGH) microarrays were previously used for this exact purpose. 
However, GWASs have the additional benefits of facilitating the discovery of new genes, 
whilst insights into genomic diversity is limited by the reference sequences used in the design 
of CGH array probes (Dutilh et al., 2013).  
Previous data from our lab has validated the utility of GWAS in developing our understanding 
of the molecular processes that government infectious disease. This technique has been used 
to develop a predictive model for predicting an isolates toxicity from its genetic signature and 
phenotypic data (M. Laabei et al., 2014b) for a Turkish collection of MRSA-ST239 isolates. 
Through assaying large number of clonally related isolates, inferences have also been made 
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regarding the high degree of phenotypic variability within this clone (Maisem Laabei and 
Massey, 2016). The final aim of this project was to study biofilm formation and protease 
production using GWAS, with the hope of uncovering novel genetic loci associated with these 
phenotypes. Chapter 3 explores the data gained through screening the Turkish ST239 strain 
collection for phenotypic variation, determining potential candidate genes through statistical 






MATERIAL AND METHODS  
Bristol Research and Development approval 
Consent to acquire the microbiological samples from the environment and staff within the 
North Bristol NHS Trust was subject to approval from their Research and Innovation 
Department. This required a detailed Project Proposal approved by their Infection Control 
team, the completion of an Integrated Research Application System (IRAS) form, separate 
Site-Specific Investigation (SSI) forms for both hospitals involved and participation 
information sheets for potential HCW participants to be assessed for ethical approval. In 
addition to this, a Research Passport was required for access to the NHS sites. In total this 
process took about 6 months due to the number of parties involved which needed to approve 
the various aspects of the project. 
Bristol sample collection 
Using sterile swabs stored in charcoal Amies transport medium (MWE), general 
microbiological samples were taken from 118 separate fomites/surfaces at the Barbara 
Russell Children’s Burns Unit, in Frenchay Hospital (Bristol) 3 months prior to the units 
relocation. A further 36 samples were taken from rooms associated with the Frenchay 
Hospital Surgical Theatre. The surgical equipment swabbed were swabbed before surgery, 
after surgery with a patient that presented with necrotising fasciitis (after surface cleaning 
with chlorine based cleaning products) and once more after a process called ‘fogging’, in 
which a vaporised cleaning solution is pumped into the theatre. The surface area of items 
swabbed was roughly kept to 1m2, or, in the case of items smaller than that, the entire 
surface area available. Additionally, staff members were asked to, anonymously, take swabs 
of the entire surface area of their right hand, their right nasal cavity and the front and back of 
their ID cards. A total of 5 doctors, 8 nurses and 4 therapy staff participated in the study. 
Finally, the new, cleaned, empty ward site, prior to the move, was swabbed as before, in 
order to gain an insight into whether any pathogens that presented a challenge after the 
move were introduced as a result of the move. 
Growth conditions for bacterial isolates from Bristol 
Mixed swab samples taken from the Bristol Children’s Burns were streaked onto both Tryptic 
Soy Agar (TSA) plates (Thermo Scientific). All growth for each item swabbed were collectively 
picked and grown overnight at 37⁰C (shaken) in 15ml of Tryptic Soy Broth (TSB), then a 1ml 
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aliquot of the inoculum was stored in a 20% glycerol in TSB solution at -80⁰C for further 
analysis at a later date. 
Verification of species diversity present within Bristol glycerol stocks 
In order to verify the efficacy of the isolation strategy used, a sub-section of the mixed-
species glycerol stocks acquired (all 69 swabs taken from the new unit) was streaked onto 
three separate varieties of selective media; Mannitol Salt Agar (for Staphylococcus spp. 
isolation), Pseudomonas Isolation Agar and Bile Esculin Agar (for Enterocococcus spp. 
isolation) and incubated overnight at 37⁰C for 18hrs, after which point the number of colonies 
per well were counted and compared.  
Bacterial propagation of ST228 
From 20% (v/v) glycerol stocks, 207 isolates of ST228 (taken from the University Hospital of 
Lausanne), 95 isolates of ST239 (taken from four separate hospitals in Turkey (Marmara, 
Istanbul, Dokuz Eylul and Hacettepe University Hospitals)), and 31 selected transposon 
mutants (see below) were plated onto TSA (Sigma-Aldrich) and incubated for 18hr at 37⁰C. 
Single colonies were then picked and inoculants propagated in 5ml aliquots of sterile TSB 
(Sigma-Aldrich) at 37⁰C for 18hr at 120rpm in glass universal tubes. 
Measuring δ toxin and PSM alpha -1, -2 and -3 through vesicle of phospholipid vesicles 
Vesicle suspensions were made from combining 75µl 25 mol % 10,12-Tricosadiynoic acid 
(TCDA), 159µl 53 mol % 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 6µl 2 mol % 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine (DPPTE) and 60µl 20 mol % cholesterol 
(suspended in chloroform). Nitrogen gas was then used to dissolve the cholesterol from the 
fatty acid components, which were then rehydrated with 10ml of 50mM 5(6)-
carboxyfluorescein (CF) in HEPES buffer and vortexed. A three times freeze/thaw cycle was 
then carried out, with the lipid suspension heated at 75⁰C for 10 min then immersed in liquid 
nitrogen for 10 min. The solution was then homogenised at room temperature for 30 min and 
extruded three times at 50⁰C through 2 100nm filter discs. The vesicles, that had 
encapsulated the CF fluorescent dye, were then purified through an Illustra Nap-25 column 
(GE healthcare) and, after 24 hrs, cross-linked with a CL1000 Ultraviolet crosslinker for 6 secs. 
In triplicate Nunc 96-well plates, 160µl of the diluted inoculum of four separate ST228 isolates 
(isolated from patient blood cultures from the years 2000, 2001, 2006 and 2009 respectively), 
was added to 40µl of the lipid vesicle solution. The samples were then grown at 37⁰C for 20 
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hrs, and fluorescence was measured at 485-12, 520em every 15min. 0.01% v/v Triton X-100 
was also analysed as a positive control while HEPES buffer was used as a negative control. The 
E. coli strain DH5α was also analysed for comparison. 
Assessment of phage susceptibility of ST228 isolates 
Phage K and Dra88, isolated by Diana Alves, were collected from crude sewage and enriched 
with various S. aureus strains. This was carried out through added 5ml of chloroform for every 
1l of crude sewage, leaving for 1 hr, then removing the resultant top layer of liquid. To this, 
5ml of an overnight culture of S. aureus (incubated at 37⁰C in TSB), 1 mM MgSO4 and 1mM 
CaCl2 were added and the mixture made up to 500ml with TSB and incubated at 37⁰C 
overnight. A 10ml aliquot of this inoculum was added to 1M NaCl (in chloroform) and the 
culture centrifuged for 30 min at 4000xg. The resultant supernatant (containing the phage) 
was then filter sterilized with a 0.22µm Millipore filter and stored at 4⁰C. Phage titer at 108 
pfu/ml were collected and diluted by SM buffer to 106, 104 and 102 pfu/mls and spotted 
onto a TSA plate containing 30ml of top agar (12g TSB to 2.6g TSA) and overnight cultures of 
ST228 isolated during 2001, 2006 and 2009 (in TSB, grown while shaken at 37⁰C). The plates 
were then incubated overnight at 37⁰C, at which point plaques within the resulting bacterial 
lawn were analysed. 
ST239 and transposon mutant propagation 
From 20% (v/v) glycerol stocks, 95 isolates of ST239, taken from four separate hospitals in 
Turkey (Marmara, Istanbul, Dokuz Eylul and Hacettepe University Hospitals), and 31 selected 
transposon mutants (see below) were plated onto TSA and incubated for 18hr at 37⁰C. Single 
colonies were then picked and inoculants propagated in 5ml aliquots of sterile TSB at 37⁰C for 
18hr at 120rpm in glass universal tubes in order to maintain optimal exogenous protein 
secretion. 
Quantifying biofilm forming potential using crystal violet staining for ST228 isolates 
In triplicate Nunc 96-well plates, 200µl of the 31 ST228 isolates taken from 2000-2009 was 
deposited in a well in each plate and grown overnight at 37⁰C. Excess media was then tipped 
out and the plates were washed three times with 200µl sterile Phosphate Buffer Solution 
(PBS). The plates were then dried at 80⁰C for 1 hr and stained with 0.1% crystal violet solution 
for 15 min. The stain was washed off three time with 200µl PBS and the resulting stained 
biofilm was then dissolved with 200µl 100% ethanol and OD measurements were made for 
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each sample at 595nm. Strain JE2 of USA300 was also analysed for comparison while PA01 
and TSB were included as positive and negative controls respectively. 
Quantifying the general production of proteases in ST239 supernatants via a milk plate assay 
Concentrated TSA (x2 concentrated, 15g in 400ml) and 100ml 50% skimmed milk solution 
(Sigma-Aldrich, Dorset, UK) were autoclaved separately, then combined and poured into 
plates. Once resulting TSA with 10% milk plates had set, they were dried for an additional 
15min. Then, in aseptic conditions, 1cm diameter wells were punched into the agar. Bacterial 
supernatants were obtained (in triplicate) through transferring 1ml aliquots of the overnight 
cultures of interest into sterile 1.5ml eppendorf tubes, then centrifuged twice for 15min at 
14000rpm, to ensure that all free-floating cells are removed from the supernatant. Aliquots of 
50µl of supernatant were then removed and pipetted into separate wells in the milk plates. 
The plates were then incubated for 18hr at 37⁰C. Zones of clearance as a result of casein 
hydrolysis within the agar were then measured to the nearest 0.25mm using a ruler.  
Modified crystal violet staining as to quantify ST239 and transposon mutant biofilm formation 
In sterile 96-well plates, with the outermost wells filled with 200µl of water, 100µl of TSB with 
0.5% glucose (Sigma-Aldrich, Dorset, UK) filter sterilised through 0.22µm filters were 
dispensed into each well. Triplicate 2.5µl aliquots of the overnight cultures were then added 
to the wells and, in high moisture conditions the plates were incubated for 24hr at 37⁰C. The 
media and any planktonic bacteria was then carefully discarded and the biofilm that formed 
at the bottom of the well was washed four times with 250µl sterile PBS. Then 150 µl of 1% 
crystal violet solution was added to each well and left for 30min at room temperature. The 
wells were again washed four times with PBS and the stained biofilm then resuspended in 
200µl 7% acetic acid. OD was then measured at 595nm. This was repeated in triplicate with 
three different inoculants per isolate. 
Selection of appropriate transposon mutants in genes significantly associated with protease 
production and biofilm formation 
Using previously obtained sequence data, a quantitative association study was conducted on 
the ST239 isolates to identify SNPs that were significantly associated with protease 
production and biofilm formation using PLINK 
(http://pngu.mgh.harvard.edu/purcell/plink)(Purcell et al., 2007). SNPs that produced a 
Bonferroni adjusted P-value <10-5 were selected as potentially affecting candidate genes. SNP 
loci in the ST239 reference TW20 (accession number FN433596) were then mapped against a 
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USA300_FPR3757 (accession number NC_007793.1) background, as this was the background 
of the transposon library available. The means through which these transposon mutants were 
produced is described elsewhere (Fey et al., 2013). The loci positions of regions that showed 
sequence homology of over 98% in USA300_FPR3757 were then inserted into the University 
of Nebraska Medical Centre’s functional genomics explorer 
(http://app1.unmc.edu/fgx/index.html) and transposon mutants in the collection with a 
transposon insertion in the gene affected by the SNP of interest in the ST239 background 
were selected for further analysis. Any SNP within an intergenic region in USA300_FPR3757 
not present in the strain collection, or located in a loci in the ST239 background with no 
homologous loci in USA300_FPR3757, or within a pathogenicity island present in ST239 but 
not found in USA300_FPR3757 were omitted. 
Production of chemically competent DH5α  
DH5α was propagated for 18hrs before being inoculated in LB (1:1000). The culture was then 
incubated at 37°C at 180 rpm for 2-4hrs to ensure an OD600 of 0.5-0.7. Cells were then chilled 
on ice for 30mins before being centrifuged for 10mins at 4°C (3000 rpm) and washed with ice-
cold deionised water. This was then centrifuged for a further 10mins at 4°C and resuspended 
in 15ml of chilled, sterile 0.1M CaCl2. These cells remained on ice for 1-2hrs before being 
centrifuged again for 10mins at 4°C. The resulting pellets were resuspended in 500μl ice-cold, 
sterile 0.1M CaCl2 containing 15% glycerol.  
Molecular cloning of wild type biofilm candidate genes into their respective transposon mutants 
Primers were designed with selected restriction sites in order to amplify loci of interest 
generated from GWAS of biofilm formation in ST239 (Appendix A) (Eurofins). These primers 
were diluted with sterile, deionized water to bring the concentration of primer to 
200pmol/ml.  Using the Phusion HF/GC DNA polymerase as instructed via their protocol 
(NEB), with the following thermocycler parameters; a) initial denaturation (98⁰C, 30 secs), b) 
denaturization (98⁰C, 10 secs), c) annealing stage (62⁰C (ccrB, sgaT and hyp) or 59⁰C (aap and 
mecA), 30 secs), d) elongation stage (72⁰C, 30 secs/kb, b-d repeated for 30 cycles) e) final 
elongation (72⁰C, 10 secs) and f) storage (4⁰C). PCR product was then purified using the 
GeneJET PCR purification kit (Thermo) and the resulting DNA yield measured using the Qubit 
DNA concentration kit (Thermo). Successful amplification was verified by running samples on 
a 1% agarose gel (85V, 30 mins).  
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All primers were either digested with EcoRI-HF (forward strands) or KpnI-HF (reverse strands) 
(NEB), with purified pRMC2 also digested with the same restriction endonucleases separately. 
In accordance with the CutSmart buffer (NEB) protocol, forward and reverse strands were 
digested concurrently in the same reaction.  All restriction digests were incubated at 37⁰C for 
30 mins. The pRMC2 backbone and digested primer pairs (one for each candidate gene) were 
then ligated using the T4 DNA ligase protocol (NEB), with the reaction incubated at 37⁰C for 
10 mins, then heat inactivated at 65⁰C for 10 mins before being chilled on ice. Aliquots of the 
ligation products were checked to ensure insertion of candidate genes through 
electrophoresis in a 1% agarose gel (85V, 30 mins). 
Chemically competent DH5α aliquots of 50µl were incubated on ice with 5µl aliquots of each 
ligation solution for 30 mins, before heat-shocking at 42⁰C and then placing on ice for 5 mins. 
The DH5α and plasmid mixtures were then added to 750µl of LB broth and incubated at 37⁰C 
for 1hr. This was centrifuged for 1min at room temperature (3000rpm) and the supernatant 
mostly discarded: any remaining supernatant was uses to resuspend the pellet. This was then 
plated out onto LB ampicillin plates at incubated for 18hrs at 37⁰C. From single colonies, the 
transformed DH5α were then propagated for 18hrs at 37⁰C, from which the pRMC2-
backbones containing the candidate genes of interest were extracted used the GeneJet Midi 
Kit (Thermo). 
Purified plasmids were then first electroporated into RN4220, then in the relevant transposon 
mutant. In both instances, the staphylococcal isolates were grown for 18hrs at 37⁰C, and 50µl 
aliquots of these overnight cultures were added to BHI and propagated at 37⁰C until an OD550 
of 0.2-0.25 is reached. These cells were washed 4 times with 3ml of filter sterilized, ice-cold 
0.5M sucrose, centrifuging at 4⁰C (3000rpm) for 10 minutes each time. After the final wash 
the resultant pellet was resuspended in 100µl of 0.5M sucrose solution. An aliquot of 100µl of 
these cells was missed with 50µl of purified plasmid and incubated on ice for 20 mins before 
electroporation using 0.2cm sterile electroporation cuvettes (Molecular BioProducts) and a 
Micro Pulser (Bio-Rad) set on their preinstalled staphylococcus settings. These cells were then 
used to inoculate 750µl of BHI before being incubated at 37⁰C for 18hrs before aliquots were 
plated on TSA containing 10 µg/ml chloramphenicol for 18hrs at 37⁰C.  
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CHAPTER 1: SURVEYING CHANGES TO THE MICROBIAL BURDEN OF A 
BURN’S UNIT CAUSED BY ITS RE-LOCATION  
INTRODUCTION 
Hospital-acquired infections represent a significant burden to healthcare services, with 
healthcare-associated infections acting as a significant cause of morbidity and mortality 
globally.  Media coverage of the rise in rates of mortality as a consequence of the various 
healthcare-associated pathogens that have emerged over the year has resulted in an 
increased awareness in the general public of the challenges faced in combating the 
emergence and transmission of pathogens in hospitals. The diversity of pathogens that can 
cause these infections, in addition to the plethora of ways in which these pathogens colonise 
the environment and evade the various strategies employed to treat their infections have 
made efficient infection control measures of paramount importance to healthcare providers 
internationally.  
Historically, various studies have highlighted the importance of various practices that can be 
employed by HCWs to reduce the spread of infection from one patient to another, such as 
maintaining a high standard of hand-hygiene, implementing compulsory reporting of 
infections and avoiding over-crowding where possible (Eames et al., 2009). However, the 
increased availability of pathogen sequence data and robust software for their analysis has 
resulted in a paradigm shift where the abundance of new insights into the transmission of 
pathogens from one patient to another may pave the way for a variety of new preventative 
strategies and infection treatments, like the changes in hospital infection control policy that 
resulted in the identification of colonisation ‘hot-spots’ in the hospital environment leading to 
the targeted cleaning efforts used in recent years (Narui et al., 2008). However, while much of 
the literature consists of phylogenetic analysis of pathogenic outbreaks that altered the 
landscape of already established bacterial flora, there have been a comparatively modest 
number of studies that have focused on the actual development of an established 
environmental microbiome in hospital settings. Of the few that have, however, a large 
proportion of these studies have done so through investigating the consequences of the 
geographical relocation of discrete clinical units.  
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The first paper to study the transmission of nosocomial pathogens as the result of the 
movement of medical equipment and personnel into another building focused on the 
University of Wisconsin Hospital’s move from a 56-year-old building to a newly-built, larger 
facility, with samples being taken from fomites, work surfaces and the air before and after the 
move. Prior to patient occupancy, significantly fewer common nosocomial pathogens were 
isolated from the hospital environment directly after it’s relocation. However, pathogenic 
species abundance and diversity both returned to pre-relocation levels 12 months after the 
move. Acinetobacter spp. and Pseudomonads were the most frequently isolated genera of 
bacteria in these screens. Interestingly, Staphylococcus aureus, although also commonly 
isolated, was seen to be just as prevalent in the new location, directly after the move, as the 
old location. This seminal paper reached the conclusion, therefore, that levels of bacterial 
contamination of a clinical environment had a negligible relationship to the incidence of post-
admission infection (Maki et al., 1982).  
A more recent study, however, investigated potential changes in MRSA transmission after the 
relocation of the Brooke Army Medical Centre to a purpose-built facility with a higher degree 
of bed segregation and one sink assigned to each room. This study involved measuring patient 
nasal colonisation by MRSA in both locations, alongside a retrospective analysis of all MRSA 
isolated from routine patient screens for 2 years prior to the move, and again 2 years after. 
Hand-hygiene compliance by healthcare workers (HCWs) was also monitored. In a similar 
finding to the previous study, they revealed that the rate of MRSA transmission did not change 
significantly after the medical centre’s relocation. This was, in part, attributed to the fact that 
rates of transmission were already deemed to be rather low, and the authors suggested that a 
more meaningful conclusion on the effects of increased patient isolation and a higher sink-to-
bed ratio could be gleaned from a similar study carried out by a ward with a higher initial pre-
move incidence of MRSA transmission (Vietri et al., 2004).  
Changes in MRSA prevalence before and after the relocation of a Chinese intensive care unit 
(ICU) from a 6-bed ward to a new 20-bed ward was carried out in 2014. Isolates of MRSA were 
acquired from both skin-and-soft-tissue swab samples, as well as from clinical specimens, from 
the patients immediate surrounding and from HCWs. In this study a significant drop of MRSA-
positive SST swabs on admission was seen in the new ward in comparison to the old one. 
However, a 3-fold increase in new cases per imported MRSA case was observed in the new 
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ward, suggesting that, in the relatively sanitised new environment, MRSA transmission 
increased. However, these findings were largely attributed to a reduced level of HCW hand 
hygiene compliance after patient contact (Chen et al., 2014). 
Given the relative lack of comprehensive investigations in changes in transmission rates of 
clinically relevant pathogens after the relocation of a clinical environment to a new building, 
likely owing to the infrequency of these relocations, a unique opportunity to study transmission 
dynamics after the move of a paediatric burn’s unit presented itself in 2014. The Barbara Russell 
Children’s Burns Unit was moved from its old site to a deep-cleaned, larger unit in a 
neighbouring hospital, providing a rare opportunity to explore what effect the relocation of 
potentially contaminated equipment and colonised medical personnel would have on the 
dissemination of pathogens in this new environment, as well as investigating the extent to 
which, if at all, species diversity is restored to levels seen in the old site, given that incidences 
such as these may provide novel insights into the extent to which transmission bottlenecks 
influence the phylodynamics of niche healthcare environments.  
This chapter focuses on an attempt to use a metagenomic approach to looking at changes in 
population dynamics of a range of potential pathogens, both before and after the move on a 
metagenomics level, in which mixed-species genomic DNA samples from individual surfaces 
and HCWs were to be sequenced in a manner sensitive enough to identify relatively sparse 
populations of bacteria and provide a snap-shot of the percentage abundance of various 
species on a particular surface in a given time point, Analysis of the resultant sequence data 
would utilise PathoScope 2.0, due to its increased scope, speed and accuracy in comparison to 




Using sterile swabs stored in charcoal Amies transport medium (MWE), general 
microbiological samples were taken from 118 separate fomites/surfaces from 20 different 
rooms within the Barbara Russell Children’s Burns Unit (Figure 4), in Frenchay Hospital 
(Bristol) 3 months prior to the unit’s relocation. The surface area of items swabbed was 
roughly kept to 1m2, or, in the case of items smaller than that, the entire surface area 




Figure 4 - Floor plan of Barbara Russell Children’s Burns Unit, with rooms swabbed highlighted 
and the reference IDs of the samples taken listed (See appendix for key) 
 
Additionally, prior to the relocation of the hospital, staff members were asked to, 
anonymously, take swabs of the entire surface area of their right hand, their right nasal cavity 
and the front and back of their ID cards. A total of 5 doctors, 8 nurses and 4 therapy staff 
participated in the sampling prior to the ward relocation. 
Prior to the move, environmental swabs were also taken from the new, cleaned, empty ward 
site, as described previously, in order to gain an insight into the indigenous bacterial flora of 
the site initially. A total of 22 swabs were taken, from surfaces in the new ward (as no 
equipment had been transferred at the time) (Figure 7). All isolates thereafter were 
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propagated and stored as advised for simultaneous pooled-sequencing. Swabs were not 
taken of the ward as anticipated 3 months after the move due to a preliminary survey of the 
microbial diversity of the samples taken previously showing a shift in microbial diversity as a 
result of the culturing technique used ( 
Table 1). 
 
Figure 5 - Floor plan of the Bristol Royal Children's Hospital, with swabbed rooms highlighted 
and reference IDs shown 
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PRELIMINARY SURVEY OF MICROBIAL DIVERSITY IN EACH SAMPLE 
Although advised to culture each swab prior to storage, a concern was raised that this step 
may have eliminated (or significantly altered) the diversity present in each swab. Given the 
expense associated with DNA extractions and sequencing of each swab, a preliminary attempt 
to determine whether a single species had out competed the others during the culturing 
stage of the storage process was undertaken using selective agar using staphylococci, 
pseudomonas and enterococci as proxy for overall species diversity.  
Table 1 Growth of Bristol environmental and staff swabs on media selective for Staphylococci 
(MSA), Pseudomonas (PIA) and Enterococci (BEA) 
 Growth on selection agar from samples collected before the move 
Sample Mannitol Salt Agar Pseudomonas Isolation Agar Bile Esculin Agar  
BRCU1-CH1 No growth No growth Lawn 
BRCU1-CH2 6-25 colonies No growth Lawn 
BRCU1-CH3 1-5 colonies No growth Lawn 
BRCU1-TSM1 No growth No growth Lawn 
BRCU1-TSM2 6-25 colonies No growth Lawn 
BRCU1-TSM4 26-50 colonies No growth Lawn 
BRCU1-CM1 1-5 colonies No growth Lawn 
BRCU1-CM2 1-5 colonies No growth Lawn 
BRCU1-CM4 No growth No growth Lawn 
BRCU1-K1 6-25 colonies No growth 50+ colonies 
BRCU1-K2 6-25 colonies No growth Lawn 
BRCU1-K3 1-5 colonies No growth Lawn 
BRCU1-K4 1-5 colonies No growth Lawn 
BRCU1-K5 No growth No growth 50+ colonies 
BRCU1-K6 26-50 colonies No growth Lawn 
BRCU1-R1 6-25 colonies No growth Lawn 
BRCU1-R2 1-5 colonies No growth Lawn 
BRCU1-R4 1-5 colonies No growth Lawn 
BRCU1-TH1 1-5 colonies No growth Lawn 
BRCU1-TH3 6-25 colonies No growth Lawn 
BRCU1-TH4 6-25 colonies No growth Lawn 
BRCU1-S3 1-5 colonies No growth Lawn 
BRCU1-S4 1-5 colonies No growth Lawn 
BRCU1-S5 1-5 colonies No growth Lawn 
BRCU1-BL2 6-25 colonies No growth Lawn 
BRCU1-BL4 1-5 colonies No growth Lawn 
BRCU1-BL5 26-50 colonies No growth Lawn 
BRCU1-BP1 1-5 colonies No growth Lawn 
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BRCU1-BP4 26-50 colonies No growth Lawn 
BRCU1-BP6 6-25 colonies No growth Lawn 
BRCU1-PT1 1-5 colonies No growth Lawn 
BRCU1-PT4 6-25 colonies No growth No growth 
BRCU1-PT5 6-25 colonies No growth Lawn 
BRCU1-Book3 1-5 colonies No growth No growth 
BRCU1-Book4 6-25 colonies No growth No growth 
BRCU1-Book5 No growth No growth No growth 
BRCU1-Toy1 No growth No growth Lawn 
BRCU1-Toy2 1-5 colonies No growth Lawn 
BRCU1-Toy3 6-25 colonies No growth Lawn 
BRCU1-Toy4 1-5 colonies No growth Lawn 
BRCU1-Toy5 1-5 colonies No growth Lawn 
BRCU1-TST1 6-25 colonies No growth Lawn 
BRCU1-TST2 1-5 colonies No growth Lawn 
BRCU1-TST3 6-25 colonies No growth Lawn 
BRCU1-TST4 1-5 colonies No growth Lawn 
BRCU1-D3 1-5 colonies No growth No growth 
BRCU1-D4 1-5 colonies No growth No growth 
BRCU1-D5 No growth No growth No growth 
BRCU1-W1 1-5 colonies No growth No growth 
BRCU1-W2 No growth No growth Lawn 
BRCU1-W3 No growth No growth Lawn 
BRCU1-W4 1-5 colonies No growth Lawn 
BRCU1-W5 6-25 colonies No growth Lawn 
BRCU1-W6 6-25 colonies No growth Lawn 
BRCU1-P1 No growth No growth Lawn 
BRCU1-P2 6-25 colonies No growth Lawn 
BRCU1-P3 Lawn No growth Lawn 
BRCU1-P4 1-5 colonies No growth Lawn 
BRCU1-P5 6-25 colonies No growth Lawn 
BRCU1-P6 6-25 colonies No growth Lawn 
BRCU1-DH1 6-25 colonies No growth Lawn 
BRCU1-DH3 No growth No growth Lawn 
BRCU1-DH4 Lawn No growth Lawn 
BRCU1-Phn1 No growth No growth Lawn 
BRCU1-Phn2 1-5 colonies No growth Lawn 
BRCU1-Phn3 Lawn No growth Lawn 
BRCU1-Phn4 6-25 colonies No growth 50+ colonies 
BRCU1-Phn5 6-25 colonies No growth Lawn 





 Growth on selection agar from samples collected from hospital staff 
Sample Mannitol Salt Agar Pseudomonas Isolation Agar Bile Esculin Agar  
N1H 26-50 colonies No growth Lawn 
N1N 6-25 colonies No growth No growth 
N1C 1-5 colonies No growth Lawn 
N2H 26-50 colonies No growth Lawn 
N2N 1-5 colonies No growth No growth 
N2C 6-25 colonies No growth Lawn 
N4H 6-25 colonies No growth No growth 
N4N 26-50 colonies 1-5 colonies No growth 
N4C 1-5 colonies No growth Lawn 
N5H 1-5 colonies 26-50 colonies No growth 
N5N 1-5 colonies No growth Lawn 
N5C No growth No growth Lawn 
N6H No growth 6-25 colonies 6-25 colonies 
N6N 6-25 colonies No growth Lawn 
N6C Lawn 1-5 colonies 1-5 colonies 
N7H 6-25 colonies No growth Lawn 
N7N 1-5 colonies No growth 51+ colonies 
N7C 1-5 colonies No growth Lawn 
N8H Lawn No growth Lawn 
N8N 1-5 colonies No growth Lawn 
N8C No growth No growth Lawn 
N9H 6-25 colonies 1-5 colonies Lawn 
N9N No growth 1-5 colonies No growth 
N9C 1-5 colonies No growth Lawn 
N10H 6-25 colonies No growth No growth 
N10N Lawn No growth No growth 
N10C 6-25 colonies No growth No growth 
D2N 26-50 colonies No growth No growth 
D3H 6-25 colonies No growth Lawn 
D3N Lawn No growth No growth 
D7H No growth No growth No growth 
D7N 6-25 colonies No growth Lawn 
D7C No growth No growth 6-25 colonies 
D8H 26-50 colonies No growth No growth 
D8N 6-25 colonies No growth 26-50 colonies 
D8C 26-50 colonies No growth 6-25 colonies 
D9H No growth No growth 26-50 colonies 
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D9N 6-25 colonies No growth 1-5 colonies 
D9C 26-50 colonies No growth Lawn 
H1H No growth No growth No growth 
H1N 1-5 colonies No growth No growth 
H1C 6-25 colonies No growth No growth 
H3H 1-5 colonies No growth No growth 
H3N 1-5 colonies No growth No growth 
H3C 1-5 colonies No growth Lawn 
H7H 1-5 colonies No growth No growth 
H7N 26-50 colonies No growth No growth 
H7C 6-25 colonies No growth 1-5 colonies 
H8H 6-25 colonies No growth Lawn 
H8N 6-25 colonies No growth 51+ colonies 
H8C 1-5 colonies No growth No growth 
 
No growth of pseudomonas, following the chosen method of culturing the collected swabs in 
TSB, was seen in any of the 69 culture samples tested, despite the fact that Pseudomonas 
aeruginosa is a relatively common hospital-acquired opportunistic pathogen, known to 
colonise clinical environments readily (Fazeli et al., 2012). Additionally, the growth of 
enterococcal species consistently and dramatically dwarfed the levels of growth seen by 
staphylococci isolated from the same area.  
DISCUSSION AND CONCLUSIONS  
 
In hindsight, the use of TSB, a selective medium, in a project largely dependent on the 
accurate and sensitive determination of the species diversity picked up in a single swab, was 
an error. The likelihood of the samples collected containing a sufficient degree of species 
diversity to accurately study changes in the population dynamics of healthcare-associated 
pathogens before and after the move of this ward was therefore too low to warrant the 
resources needed to take the project further, given that a second collection of the burns’ unit 
prior to the move is no longer possible.  
In this instance, while it would not have been appropriate to have carried the project on, the 
high incidence of nosocomial infection in paediatric burns’ patients warrants investigation into 
the potentially unique transmission chains that represent such a significant burden currently. 
Nosocomial transmission of pathogens to burn wounds have historically been largely 
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associated with direct contact of the burn to the colonised hands of healthcare workers (Church 
et al., 2006). And while poor infection control practices do increase the risk of nosocomial 
infection, good hygiene practices sadly are not enough to prevent MRSA transmission from 
staff to patients. The increase of MRSA carriage caused by close contact to patients is of 
particular concern in a burns unit, since patients are regularly in close contact with staff for 
wound debridement and dressing changes (Albrich and Harbarth, 2008). Therefore, 
determining effective treatment strategies through increasing our understanding of the 
population dynamics of common pathogens is of paramount importance. 
Should another opportunity arise to study changes in pathogen transmission and population 
dynamics as a consequence of a ward or hospital’s physical relocation to a new site, the 
potential novelty and utility of using a similar pooled-sequencing approach to the resultant 
metagenomics analysis should not be discounted. 
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CHAPTER 2: IDENTIFYING PHENOTYPIC DIFFERENCES ASSOCIATED WITH 
A S. AUREUS OUTBREAK IN A TERTIARY CARE HOSPITAL. 
THE LAUSANNE ST228 COLLECTION  
The MRSA strain ST228, also known as the South German Epidemic strain or the Italian clone, 
is a multiply antibiotic resistant genotype belonging to the clonal complex (CC) 5, which, along 
with CC8, are the most prevalent CCs worldwide. ST228 is largely prevalent in central 
European countries, including Germany, Italy, Austria and Switzerland (Monecke et al., 2009) 
(Figure 6). 
 
Figure 6 - The prevalence of the MRSA clone ST228 within central Europe (Dominique S Blanc; 
personal communication). 
ST228-MRSA-I was first detected in Switzerland in the late 90s and its spread has been 
restricted between Geneva and Lausanne tertiary care hospitals. In addition to this strains 
geographical isolation, within the tertiary care hospital of Lausanne, this clone became 
responsible for two outbreaks during 2001 and late 2003/early 2004. The prevalence of this 
clone then diminished, at which point the hospital considered its infection control procedures 
to have been effective. However, as a precaution the hospital continued to implement these 
practices (Dominique Blanc, personal communication). Despite this, however, during late 
2008, another epidemic was observed, with the strain disseminating at an unusual rate, 
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affecting over 500 patients within a year and a half, despite other clones remaining relatively 











In a genomic analysis of eight isolates collected in 2001, 2006 and 2008, Vogel et al. (2012) 
determined that all of the isolates were genetically very closely related, with most variation 
consisting of just a few SNPs and INDELs (insertions and deletions of nucleotides). Whatever 
genetic differences were observed could not be linked to the sudden spreading success of the 
strain (Vogel et al., 2012b). However, the group highlighted that this may not necessarily 
mean that the cause of the outbreak had no genetic basis. A plausible case can be made that 
changes in phenotype that may have resulted in the rapid dissemination of the clone in 2008 
could be a result of a multitude of additional factors that could mask a genetic cause for the 
breakout (for instance changes in post-transcriptional regulation). Thus it was theorised that 
the cohort would benefit a study of phenotypic variation at different times of isolation, after 
which point any phenotypic differences between outbreak isolates and those isolated during 
non-outbreak years can be studied molecularly across the strain collection. 
BIOFILM FORMATION 
Given the propensity of S. aureus to persist in clinical environments through colonising 
medical equipment and surfaces, an analysis of the isolates taken at different year’s ability to 
Figure 7 - The number of cases of patient with positive swabs for various 
sequence types of MRSA (ST228 in red) (Vogel et al., 2012b). 
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form biofilms was carried out. A microtiter biofilm assay that utilised crystal violet staining as 
a means of measuring adherence to the base of a 96-well plate was performed (Figure 8). 
 
 
Figure 8 - Biofilm formation of 31 ST228 isolates, as shown through relative retention of 
crystal violet, measured through OD595 (n=31), standardised against negative TSB control. * 
coincide with years in which a perceived outbreak of ST228 had occurred. Error bars represent 
standard deviation (SD) 
 
The biofilm data collected for the ST228 isolates were unusually low (view Fig. 20 as a point of 
comparison), given that the average biofilm production seen in low-biofilm producing clones 
are known to have OD595 of orders of magnitudes higher than is depicted in Figure 8. 
Additionally, the large standard deviation (relative to the OD figures reported) suggest little 
variation in the biofilm production of ST228 isolates throughout the years the hospital was 
under surveillance. 
δ toxin and PSM alpha-1, -2 and -3 production in ST228  
The agr operon acts as a population-density dependent quorum-sensing transcription 
modulator. In a recently developed high-throughput assay, it was discovered that the agr 
activity of stains of S. aureus could be analysed through the detection of the lysis of lipid 
vesicles encapsulating a fluorescent dye through the action of δ toxin and PSMs (-α, -β, -γ and 
–δ), two essential classes of toxin involved in MRSA virulence (Maisem Laabei et al., 2014a). 
To gain an appreciation for the strains variation in toxin production the aforementioned 
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vesicle lysis test was used to assess the activity of the agr operon for the ST228 isolates and 
whether any changes in agr activity could be observed during the outbreak periods (Figure 9).  
 
Figure 9 - Lipid vesicle lysis by ST228 isolates from 2000, 2001, 2006 and 2009, in comparison 
to Triton (positive control), HEPES buffer and DH5α (negative controls) (n=4.  Error bars 
represent SD 
ST228 displayed low production of δ toxin and PSMs, with levels of vesicle lysis comparable to 
the avirulent DH5α E. coli strain (Figure 9). No change in toxicity was observed between 
isolates taken from epidemic years and those taken from when ST228 was of less concern to 
the hospital.  
 
Phage susceptibility of ST228 
Given the number of bacteriophage that form part of the natural human microbiota, changes 
in phage susceptibility by a bacterial strain may result in a change in their ability to persist 
within a human host. With this, the susceptibility of ST228 to both Phage K and Dra88 (used 
due to their generality in terms of the number of host strains they are able to infect) was 
briefly assessed through spotting a solution containing these phages on a bacterial lawn of 3 
ST228 isolates taken in 2001, 2006 and 2009 (with 2001 seeing a slight increase in the 
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incidence of infection, and 2009 being the year that the number of infections were highest), 
at various pfu/ml concentrations (Figure 10). 
 
Figure 10 - Phage K (left of each plate) and Dra88 (right of each plate), at 108, 106, 104 and 
102 pfu/ml, spotted onto a lawn of ST228, isolated at 2001 (1), 2006 (2) and 2009 (3) 
 
All isolates tested showed a high degree of susceptibility to both phages tested, with cell lysis 
seen even at 102 pfu/ml (Figure 10). Following this, an analysis of the growth of these 3 ST228 
isolates overnight was studied, with phage added 2 hours after the isolates initial incubation 




Figure 11 - The growth of ST228, as measured through OD600, isolated during 2001, 2006 and 







In Figure 11 it is observable that both phages effectively lysed all isolates of ST228 studied, 
with little variation observable between samples isolated in 2006 (a non-outbreak year) and 
2001/2009 (years in which an outbreak occurred). However, the collective data from the 
phage susceptibility experiments suggest that no difference in phage susceptibility occurred 
that could be correlated to the various ST228 outbreaks in Lausanne. 
CONCLUSIONS 
For the four phenotypes studied, biofilm formation, rhamnolipid vesicle lysis and phage 
susceptibility, no observable significant differences were seen between the representative 
subset of the collection studied. This suggested that external factors outside the scope of this 
investigation may be responsible for the outbreak. These factors might have a molecular basis 
outside of the genome. For instance, around 250 regulatory RNAs (sRNAs) are putatively 
involved in the intricate coordination of staphylococcal genes. The mRNA targets of a large 
proportion of these sRNAs is largely unknown (Guillet, Hallier and Felden, 2013). 
Another potential factor that led to the ST228 outbreak might be the efficacy of the infection 
control protocol followed at the time. This might be the result of a small number of HCWs not 
adhering to the measures, or perhaps the measures taken were not comprehensive enough. 
Contamination of bed linen, for example, is increasing seen as a clinical fomite that often are 
not adequately decontaminated between patients (Creamer and Humphreys, 2008).  
Finally, it is worth noting that the range of phenotypes tested in this study was far from 
comprehensive. Amongst the various other phenotypic factors that could have been included 
in this study were proteases, for instance staphopain B (a protease which degrades host 
fibronectin and fibrinogen) is putatively involved in S. aureus dissemination (Kolar et al., 
2013), fibrinogen- and fibronectin-binding or antibiotic resistance. 
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CHAPTER 3: DETERMINING NOVEL CANDIDATE GENES ASSOCIATED 
WITH PROTEASE PRODUCTION AND BIOFILM FORMATION THROUGH A 
GENOME-WIDE ASSOCIATION STUDY OF A POPULATION OF ST239 
INTRODUCTION 
ST239 is an epidemic clone of MRSA, accounting for a significant proportion of MRSA 
infections worldwide (Boswihi, Udo and Al-Sweih, 2016). The clone’s success has been 
attributed in part to the variability of the gene 
expression of their virulence factors. In a 
comprehensive study of the variability of adhesin 
and toxin production in a collection of ST239 
isolates by this group, taken from a variety of 
different types of infections in four Turkish 
hospitals, it was observed that a high degree of 
variability existed between the toxicity of these 
strains. Using GWAS, a number of genetic loci were 
seen to be significantly associated to toxicity, 
including a number of novel loci that were not 
previous considered toxicity regulating loci. In 
addition it was observed that a switch in expression between toxicity and adhesion genes is 
vital in facilitating the opportunistic nature of S. aureus (M. Laabei et al., 2014b). 
Given that both the whole genome sequencing data for the entire ST239 collection and the 
bioinformatics pipeline required to perform the GWAS were already in place, it was decided 
to use the approach of the study described about to test other phenotypes important to the 
virulence of ST239. 
Protease production is a vital component of staphylococcal pathogenicity. A variety of 
proteases, which cleave different consensus amino acid sequences of their target proteins 
and are known to often auto-activate themselves in a proteolytic cascade that results in the 
zymogens of a number of major proteases (Aur, SspA, SspB and ScpA) activating to exert their 
extracellular function (Shaw et al., 2004). However, little has been published regarding the 
regulation of these genes by pleiotropic loci, thus making protease activity an attractive 
Figure 12 - ‘Zones of clearance’ 
observed on a standard milk agar plate 
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phenotype to study through GWAS. Another interesting phenotype that is important in MRSA 
virulence is biofilm formation. Biofilms are an integral means through which S. aureus persists 
on surfaces, defends itself further against antimicrobial action and concentrating 
environmental nutrients (Otto, 2008). Additionally, biofilms play a critical role in the 
progression of chronic disease; once a biofilm has been established in a host, individual cells 
can then disperse to colonise new sites of infection (Lister and Horswill, 2014). 
The following chapter details the initial steps taken towards using GWAS to explore potential 
new genes important for protease production and biofilm formation within a collection of 
clinical MRSA-ST239 isolates. 
RESULTS 
Protease activity varies considerably between individual isolates of ST239 
A subset of 95 isolates of ST239 samples were taken from four different university hospitals in 
Turkey between 2006 and 2009 from a variety of different sources, including wound 
infections, blood infections, catheters, spinal fluid and abscesses. Supernatant from the 
overnight cultures of these isolates were dispensed into wells within TSA with 10% milk and 
incubated overnight.  The resultant ‘zones of clearance’ were formed from the supernatant 
diffusing out of the well, and any proteases within the supernatant degrading casein, the 
opaque protein found in milk, resulting in a clearance in the wells (Figure 14).  The width of 
these zones of clearance, rounded to the nearest 0.25mm, was used as a high-throughput 
means of quantifying the overall protease production of each isolate. An agr+ and agr- MRSA 
strain, RN6390B and RN4220 respectively, provided positive and negative controls, due to the 
established relationship between agr functionality and protease production (Lauderdale et 
al., 2009) (RN4220 consistently and unambiguously produced halos of 1.5mm in diameter) 
while TW20 , the reference strain, was also included as a point of reference (Figure 13). 
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Figure 13 - Average protease activity of ST239 isolates taken from four hospitals in Turkey 
(MU, IU, DEU and HU taken from Marmara, Istanbul, Dokuz Eylul and Hacettepe University 
Hospitals respectively) measured through casein hydrolysis in milk agar plates (n=3). Error 
bars represent SD 
 
The zones of clearance observed from the diffusion of the ST239 isolates supernatants 
through the milk agar showed some degree of variability (Figure 13), notably the diffusion of 
isolates MU12 and IU12 supernatants consistently did not result in any observable clearness 
in the agar surrounding the well whereas the supernatant of isolates MU13 and MU14 had 
zones of clearance comparable to the agr+ control supernatants.   
To assess whether any difference in the average protease production could be observed in 
samples isolated from different types of infections (abscesses, aspiration infections, 
bacteraemias, catheter related infections, spinal fluid infections, positive sputum samples, 
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positive tracheal secretion samples and positive wound swabs specifically), the results gained 
from the milk agar plate assay were analysed to account for the various sources of isolates 
(Figure 14). 
 
Figure 14 - Average protease activity of ST239 samples isolated from different types of 
infections of patients from four Turkish hospitals. Error bars represent SD 
No significant differences were observed when the average protease production of samples 
isolated from abscesses, aspirations, blood, catheters, spinal fluid, sputum, tracheal secretion 
and wounds were calculated. Although this may be a consequence of having been grown in 
the same conditions, this suggests no intrinsic difference in protease gene expression under 
standard laboratory conditions.  
SNPs with significant association to protease activity and transposon mutants in a USA300 
FPR3757 background for verification of their significance 
Using the protease data gained through the milk plate assay for the entire collection (apart 
from MU12, MU13 and MU14 due to lack of sequence data for these isolates) and previously 
collected whole genome sequencing data, significantly associated SNPs were found through 
data analysis using PLINK (carried out by Dr Mario Recker). Loci containing the top 50 SNPs 
were mapped against a USA300 FPR3757 reference genome and available transposon 





























Table 2 - Turkish ST239 SNPs with the highest P-value for protease activity when compared to 
the TW20 reference 





Name/function of affected 
loci in TW20 






0.000187 2393426 murA SAUSA300_2078 NE939 
0.000187 2377659 atpH SAUSA300_2061 NE1889 
0.000187 2174068 agrC SAUSA300_1991 NE873 
0.000187 2997008 lip SAUSA300_2903 NE338 
0.000197 2775786 sarU SAUSA300_2438 NE96 
0.000272 2106193 hypothetical membrane 
protein 
SAUSA300_1919 NE1805 
0.000272 2845228 copper-translocating P-type 
ATPase 
SAUSA300_2494 NE561 
0.000272 1935622 oxidoreductase, aldo/keto 
reductase family 
SAUSA300_1728 NE1441 
0.000272 2178247 scrR, sucrose operon repressor SAUSA300_1995 NE742 
0.000272 1904373 cell wall surface anchor family 
protein 
SAUSA300_1702 NE56 
0.000272 2532617 putative membrane protein SAUSA300_2211 NE627 
0.000286 78396 mecA, penicillin-binding 
protein 2' 
SAUSA300_0032 NE1868 




0.000286 967656 putative membrane protein SAUSA300_0817 NE499 
0.000312 1423837 catalase SAUSA300_1232 NE1366 
0.000349 435458 glycerol-3-phosphate 
transporter 
SAUSA300_0337 NE1388 
0.000349 1067541 mgtE, magnesium transporter SAUSA300_0910 NE736 
0.000349 1184963 cyoE, protoheme IX 
farnesyltransferase 
SAUSA300_1016 NE1434 
0.000349 214537 putative N-acetylmuramoyl-L-
alanine amidase 
SAUSA300_0181 NE1190 
0.000349 1171002 mntH, manganese transport 
protein 
SAUSA300_1005 NE1097 
0.000349 1148420 hypothetical protein SAUSA300_0982 NE1788 
0.000349 15605 hypothetical protein SAUSA300_0011 NE1827 
0.000349 948986 PAP2 family protein SAUSA300_0794 NE620 
0.00043 78119 mecA, penicillin-binding 
protein 2' 
SAUSA300_0032 NE1868 
0.000453 1121452 fmt, fmt protein SAUSA300_0959 NE1022 





0.000753 2147952 phi77 ORF014-like protein, 
phage anti-repressor protein 
SAUSA300_0982 NE1786 
0.000836 2753734 Intergenic region Position 
2601099 
NE1482 
0.000889 220518 rocD, ornithine 
aminotransferase 
SAUSA300_0187 NE1069 
0.000889 1029240 cdr, coenzyme A disulfide 
reductase  
SAUSA300_0873 NE1456 
0.000889 761112 Na+/H+ antiporter SAUSA300_0617 NE1504 
 
A variety of loci potentially affected by SNPs were determined, and isolates in a 
USA300_FPR3757 background with transposon insertions in regions homologous to these loci 
in the ST239 reference strain JE2 were identified. The rationale behind looking for these 
transposon mutants can be explained when the p values displayed in Table 2 are observed. 
GWAS are often prone to producing a high number of false positives due to linkage 
equilibrium (Power, Parkhill and de Oliveira, 2016). Thus, for example, the four ‘most highly 
associated’ loci (murA, atpH, agrC and lip) all have the same p value (0.000187), which 
suggests that only one of these loci are actually associated with the protease phenotype. As a 
result, validation of which loci are truly associated is required. 
Functional verification of the effect of GWAS associated loci on protease activity  
In an effort to elucidate which of the seemingly associated SNPs in certain genetic loci had a 
genuine effect on the average production of general proteases, transposon mutants in a 
USA300_FPR3656 background, with transposon insertions in genes corresponding to the 
affected loci in the ST239 cohort, were then isolated and the proteolytic activity of these 
mutants quantified through supernatant diffusion through milk agar (Figure 15). 
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Figure 15 - The average decrease in protease activity of USA300_FPR3757 isolates with 
transposon insertions in the specified gene when compared to JE2. (n=3). Error bars represent 
SD 
The top 50 SNPs that associated significantly with protease activity were used, which were 
relatively evenly distributed across the genome, with the exception of those that fell within 
the SaPI 1 (S. aureus Pathogenicity Island 1).  
Every transposon insertion in genes affected by SNPs shown to have an association with a 
change in protease activity resulted in a decrease in protease activity, except, surprisingly, 
agrC, where inactivating the locus through the insertion of a transposon had a seemingly 
negligible effect on general protease production in USA300_FPR3757. Of the transposon 
mutants screened SAUSA300_2494 (a copper-translocating P-type ATPase encoding gene) and 
SAUSA300_1728 (an oxidoreductase, aldo/keto reductase family protein encoding gene) 
stood out as having the lowest decrease in protease activity when compared to JE2 (the 
USA300_FPR3757 reference strain), whilst murA had the largest decrease in protease activity. 
However, the USA300_FPR3757 background had significantly lower protease activity than the 
ST239 population, and the large degree of error seen in these data may be a consequence of 






























An inverse correlation exists between general protease production and lytic activity in ST239 
A previous analysis of lytic potential of these ST239 isolates was carried out  and, 
interestingly, the isolate with the highest lytic potential HU13 had the sixth lowest proteolytic 
potential out of a cohort of 95 in the milk plate assay while the isolate MU9, with the lowest 
lytic potential, exhibited a moderate proteolytic phenotype. This prompted a brief 
comparison of average protease activity of the most and least toxic isolates of the Turkish 
ST239 collection, using the aforementioned vesicle lysis assay (data provided by Maisem 
Laabei) and the aforementioned measurements of casein hydrolysis by proteases present in 




Figure 16 – The average protease activity of the most and least lytic* ST239 isolates in 
the Turkish collection (n-10) (unpaired, single tailed Student's t test - p>0.0001 
(denoted by ****, t=6.2343, df=18) *lytic activity determined through alpha toxin and 
PSM 
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The average width of agar clearance in the ten ST239 isolates with the lowest lytic potential 
at the exponential phase of growth was significantly larger than that of the ten most toxic 
isolates (Figure 16). Interestingly, when this same comparison was carried out with the 
most and least lytic isolates of a collection of USA300 isolates (Maisem Laabei et al., 2015) 
no significant different in proteolytic activity was observed.  
Biofilm formation in ST239 isolates 
Individual overnight cultures of the Turkish ST239 isolates were added in 1 in 40 dilution to 
TSB with 0.5% glucose, and the resultant biofilm formed at the bottom of each 96-well 
after incubation was stained with 1% crystal violet, the excess stain washed with PBS and 
the stained biofilm resuspended in 7% acetic acid. Through this the OD at 595nm can be 
used to quantify the biomass that accumulated at the bottom of the well. LAC and EMRSA-
15 were both used as positive controls for this assay, which are done in triplicate on three 
separate 96 well plates, with three technical repeats per plates used. Variations per plate 
were then accounted for by blanking against the average OD of the TSB negative control 
wells and the results were shown as a percentage of EMRSA-15, a reliable biofilm former 




Figure 17 - Average biofilm formation of ST239 isolates taken from four hospitals in Turkey 
(MU, IU, DEU and HU indicting isolates taken from Marmara, Istanbul, Dokuz Eylul and 
Hacettepe University Hospitals respectively) measured through crystal violet staining (n=3). 
Error bars represent SD 
 
As with the protease production data, despite the clonal nature of the collection, there was a 
large degree of variation observable within the collection as a whole, with some variation 
observable when the total average biofilm formation for individual hospitals are compared. 
Notably, MU12, MU13 and MU14 consistently failed to produce strong biofilms, as did IU9, 




SNPs with significant association to biofilm formation and transposon mutants in a USA300 
FPR3757 background for verification of their significance 
Using the biofilm data gained through the crystal violet staining assay for the entire collection 
(apart from MU12, MU13 and MU14 due to lack of sequence data for these isolates) 
and previously collected whole genome sequencing data, significantly associated SNPs were 
found through data analysis using PLINK (carried out by Dr Mario Recker). Loci containing the 
top 50 SNPs were mapped against a USA300 FPR3757 reference genome and available 
transposon mutants with the Nebraska Transposon Mutant Library were located, the most 
relevant of which are listed in Table 3. 
Table 3 - Turkish ST239 SNPs with the highest -log P-value for biofilm formation when 
compared to the TW20 reference 






Name/function of affected gene in 
TW20 






1698548 1684374 hypothetical protein SAUSA300_1534 NE1210 
17463 17392 ccrB (cassette chromosome 
recombinase B) 
SAUSA300_0037 NE495 
655782 584731 methyltransferase small subunit SAUSA300_0526 NE1671 
1982993 1958590 hypothetical protein SAUSA300_1771 NE68 
2514045 2362155 secY SAUSA300_2184 No Tn 
2637384 2485589 mqo (malate:quinone oxidoreductase) SAUSA300_2312 NE1003 
2987716 2821611 hypothetical protein SAUSA300_2593 NE1618 
366127 363875 nupC (putative nucleoside permease) SAUSA300_0313 NE622 
428285 384011 sgaT (transport protein) SAUSA300_0330 NE758 
553689 482991 mecA (PAP2 family protein) SAUSA300_0429 NE620 
565190 496216 hypothetical protein SAUSA300_0443 NE1831 
1545621 1488076 cell surface protein SAUSA300_1327 NE1 
1641720 1614525 6-phosphogluconate dehydrogenase SAUSA300_1459 No Tn 
1671901 1657762 hypothetical protein SAUSA300_1505 NE377 
2520835 2368497 rpsS (30S ribosomal protein S19) SAUSA300_2200 No Tn 
2603650 2451267 hutU (urocanate hydratase) SAUSA300_2278 NE435 
2681927 2529787 Zn-binding lipoprotein adcA-like 
protein 
SAUSA300_2351 NE568 
2731802 2578578 an amino acid permease SAUSA300_2395 NE1131 
211613 203715 non-ribosomal peptide synthetase SAUSA300_0181 NE119 
830266 758921 fructose specific permease SAUSA300_0685 NE768 
1834421 1814651 dnaE (DNA polymerase III alpha 
subunit) 
SAUSA300_1649 No Tn 
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A variety of loci potentially affected by SNPs were determined, and isolates in a 
USA300_FPR3757 background with transposon insertions in regions homologous to these loci 
in the ST239 reference strain JE2 were identified. Again, due to the prevalence of false 
positives in GWASs, validation of which of the listed loci in Table 3 have a true association 
with biofilm is necessary before any conclusions can be drawn.   
Functional verification of the effect of GWAS associated loci on biofilm formation  
In the same vein as the approach taken in the study of protease activity for this collection of 
isolates, to try and eliminate false positive associations, transposon mutants in the 
USA300_FPR3656 background, with transposon insertions in a number of the candidate genes 
listed in Table 3 were isolated and biofilm formation was quantified through microtiter 
crystal-violet staining (Figure 19). 
 
 
Figure 18 - The average biofilm formation of USA300_FPR3757 isolates with transposon 
insertions in GWAS generated candidate loci (see Table 3 - Turkish ST239 SNPs with the 
highest -log P-value for biofilm formation when compared to the TW20 reference, compared 
to JE2 background strain (n=3). Error bars represent SD. * denotes p<0.05 between a 




























* * * 
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The average biofilm formation of candidate genes generated from the GWAS study of the 
ST239 cohort were studied using analogous transposon mutants in the USA300_FPR3757 
background whose ability to produce biofilms were compared to that of JE2, the reference 
strain for this collection. A two-tailed, paired T-test showed the following transposon mutants 
average biofilm formation were significantly lower (p < 0.05) than the JE2 reference strain (P 
values are as follows: NE495, p=0.00449; NE620, p=0.024669; NE758, p=0.0368; NE1131, 
p=0.0442; NE1210, p=0.0402; NE1868, p=0.0449). These numbers represent isolates from the 
USA300_FPR3757 with transposon mutants in the following genes respectively; ccrB, mecA, 
sgaT, a gene responsible for encoding an amino acid permease and a hypothetical protein (for 
convenience, these shall be referred to as aap and hyp respectively for the remainder of this 
report). These genes were therefore chosen for further analysis for their effect on the biofilm 
formation capabilities of USA300_FPR3757 through complementation analysis. 
Complementation of candidate genes involved in biofilm formation 
Following the establishment of a list of candidate genes with a potential association with 
biofilm formation (Table 3) and the comparison of the biofilm production of these transposon 
knockouts against the USA300_FPR3757 reference strain, 5 candidate genes (mecA, ccrB, 
sgaT, aap, and hyp) were amplified in the purified genome from wild-type JE2, through the 
use of primers containing appropriate restriction sites flanking the insert (see Appendix 1). 
These amplicons were then cut using the appropriate restriction enzymes and ligated 
between the corresponding cut restriction sites within the tetracycline inducible plasmid 
pRMC2. The success of the ligation of the amplicon to the pRMC2 backbone was assessed 
through 1% agarose gel electrophoresis.  
Successfully spliced vectors were transformed into chemically competent Escherichia coli 
vectors, DH5α, through heat shock. These transformed DH5α isolates were then propagated 
in media containing tetracycline to select for successful transformants. pRMC2 plasmids 
containing one of the 5 candidate genes was purified, amplified and then inserted into a 
second conduit, RN4220, through electroporation to ensure that the resulting post-
translational modifications on the plasmids are appropriate for insertion into their 
corresponding transposon mutants (reducing the possibility of the insert being degraded). 
Transformed RN4220 propagation and DNA purification and amplification occurred as 
previously described, with the resultant plasmids (each containing one of the five 
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aforementioned candidate genes) were then electroporated into the corresponding 
transposon mutant. A crystal violet staining assay was then used to compare the biofilm 
formation of the transposon mutants to their complemented counterparts (Figure 19). 
 
 
Figure 19 - Biofilm formation (as a percentage of OD595 of MRSA-15) of transposon mutants 
of candidate genes and their compliments (n=9). Error bars represent SD 
For the 5 candidate genes focused on here (mecA, ccrB, sgaT, aap and hyp respectively), no 
significant difference in biofilm formation was observed between the transposon mutants and 
isolates that had a functional version of the candidate gene reintroduced (Figure 19)(paired 
student t-test p values as follows: mecA (p=0.137), ccrB (p=0.118), sgaT (p=0.183), aap 
(p=0.269) and hyp (p=0.339)). The biofilm formation for the majority of the transposon 
mutants also now had, curiously, no statistical difference in biofilm formation against the wild 
type reference JE2, calling the integrity of the dataset into question. 
Correlations between the all currently known phenotypes of the Turkish ST239 collection 
Previous work carried out by this lab have investigated a number of other phenotypes of 
these 95 ST239 isolates, including fibrinogen binding, fibronectin binding and lytic activity 







































formation and protease production added to this wealth of phenotypic information, a series 
of Pearson’s rank correlation tests were performed on the data set to try and elucidate 
whether any observable correlations existed between all the phenotypes tested (Table 4). 
The only phenotype that showed a significant correlation to protease activity was vesicle lysis 
at the exponential stage of culture growth (Table 4) as mentioned previously. All positive 
correlation between fibrinogen and fibronectin binding is as expected, however, the lack of 
other statistically significant correlations between the other phenotypes described is worthy 
of note. 
Table 4 The Pearsons’ rank correlations of various phenotypes known for a collection of ST239 
isolates taken from four Turkish hospitals. Acronyms represent the following phenotypes (Fb; 
Fibrinogen binding, Fn; Fibronectin binding, VL; Vesicle lysis (measuring δ toxin and PSMs 
production, Pr; Protease production, Bio; Biofilm formation) (-Ex/-St denote the phase of 
growth of the isolates at which measurements were taken: exponential phase and stationary 
phase respectively). Figures represent the raw Pearsons’ rank correlation coefficient data, with 
figures highlighted in green representing statistically significant linear positive correlations 
between two phenotypes, while those in blue highlight statistically significant linear negative 
correlations between two phenotypes (p>0.05) 
Pearsons rank         
Correlation 





Fb-Ex   0.526 0.61 0.552 
-
0.051 -0.076 0.152 
-
0.079 
Fb-St 0.526   0.496 0.842 0.029 -0.147 0.204 
-
0.146 
Fn-Ex 0.61 0.496   0.638 
-
0.292 -0.201 0.166 
-
0.275 
















0.106 0.284   -0.622 
-
0.022 













0.133 0.288 -0.022 0.042   
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DISCUSSION AND CONCLUSIONS  
General protease production was assayed through a high-throughput decanting supernatant 
into milk agar plates. Clear differences were observed within the cohort of these highly 
related clones, MU13 and MU14 both exhibiting zones of clearance around 5x larger in width 
than the average for isolates from that hospital, while MU12 and IU12 supernatants 
consistently did not produce any observable clearance. Despite the high degree of variation of 
protease production in isolates from within the same hospital, little variation was observable 
between isolates from the different hospitals. When transposon mutants in a 
USA300_FPR3757 background with transposon insertions in homologous regions to the 
various potentially associated loci were analysed for protease production using the milk plate 
assay were analysed, however, no clear differences in the transposon mutants protease 
production was observed. This is the likely consequence of the USA300_FPR3757 background 
not being as proteolytic as ST239, suggesting that a more sensitive assay is required for more 
consistent results. When protease activity was compared to toxicity in the ST239 collection, 
an inverse relationship was observed, however, given the multiple regulators that may be 
influencing both phenotypes, the exact regulators responsible for this trend have not been 
determined. 
Within the cohort of ST239 isolates, a high degree of variation in biofilm formation was 
observed overall in the population, making biofilm formation another interesting candidate 
phenotype to study further through GWAS. An interesting observation when the entire 
cohort’s phenotypic data were statistically compared was the lack of correlation between 
biofilm formation and toxicity, as both phenotypes are tightly regulated by the agr quorum 
sensing system. Within the agr system, δ toxin (one of the toxins the aforementioned vesicle 
lysis test is sensitive to) is encoded within the coding sequence of RNAIII: the agr systems 
effector molecule. Most PSMs are upregulated in the presence of agrA (Queck et al., 2008). 
The agr system has also been described as an important factor in the initial stages of biofilm 
formation (Boles and Horswill, 2008). However, this may be a consequence of the large 
standard deviations produced by the assay (Fig. 21) which is an expected outcome of a  
microtiter biofilm assay with particularly strong biofilm formers. This is due the assays 
propensity to detach more loosely adhered biofilms during wash steps, particularly at a higher 
biomass (Joana Azeredo et al., 2017b).   
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Five candidate genes (mecA, ccrB, sgaT, aap and hyp) were shown to have a potential 
association with biofilm formation, however subsequent complementation analysis failed to 




AIM 1: SURVEY CHANGES TO THE MICROBIAL BURDEN OF A BURN’S UNIT CAUSED BY ITS RE-
LOCATION 
 
The relocation of the Bristol Children’s Burns Unit into a larger, more modern hospital offered 
a rare opportunity to study any changes in the ecology of hospital-pathogens within the niche 
clinical environment of a paediatric burns unit. A number of swabs were taken from surfaces 
and fomites within several rooms in the ward, as well as swabs of the hands, nasal passages 
and identification cards of consenting healthcare workers that worked at the unit. These 
swabs were taken both before the relocation and after, with an additional set of swabs taken 
in the newly emptied and cleaned new ward prior to the move. 
However, unfortunately, all samples collected as part of this sub-project were propagated in 
TSB at 37⁰C. In hindsight, this error hampered the project, resulting in the samples obtained 
no longer representing the true microbial diversity of the clinic. This demonstrates the value 
of thorough experimental design, with particular attention given to the sampling – the most 
important step in any metagenomics project (Thomas, Gilbert and Meyer, 2012b).   
General advice regarding isolation and extraction require a large yield of high quality nucleic 
acids that are representative of the diversity of the microbial community sampled. 
Commercially available DNA isolation kits designed for metagenomic analysis are often 
designed for testing soil or water sample contamination. This is because propagating bacterial 
populations using enriched nutrient media, such as TSB (chosen in this instance for its ability 
to support the growth of a wide-variety of microorganisms) will invariably influence the 
population dynamics of a sample (Greninger et al., 2017). 
A more appropriate approach to the sample collation may have been through directly 
inoculating water with the swabs used to take the samples as opposed to using the charcoal 
Amies transport medium used in this instance. Additionally, a prudent measure during the 
early stages of this investigation would have been to have developed a tested, bespoke 
protocol for the isolation of metagenomic DNA from environmental swabs prior to the 
hospitals relocation. This would have also informed the approach planned for the subsequent 
stages of the study. For example, given that certain types of samples (such as ground-water or 
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biopsies) have been shown to provide DNA yields too low for sequencing, amplification of the 
starting genetic material prior to sequencing may well have been required post-sampling, 
most commonly through multiple displacement amplification (Thomas, Gilbert and Meyer, 
2012b). 
Should the microbial diversity not have been skewed through sampling error, the intended 
next step would have been to using shotgun metagenomic sequencing, an approach that 
randomly shears all DNA in a sample into fragments which can then be sequencing through 
standard next-generation sequencing methods. If sequenced deeply enough, the resulting 
reads were then intended to be assembled using a metagenomic analysis framework capable 
of profiling at the subspecies level, PathoScope 2.0 (Hong et al., 2014). The output from this 
analysis would have provided important information regarding the ecology of both benign 
and pathogenic bacteria within a clinical setting and, crucially, provided information that 
could then have been used to observe any shift in transmission dynamics caused by the 
relocation. Another interesting avenue to explore might have been assessing which colonisers 
of the ward environment played the largest role in the recolonization of the ward 
environment.   
AIM 2: IDENTIFY PHENOTYPIC DIFFERENCES ASSOCIATED WITH A S. AUREUS OUTBREAK IN A 
TERTIARY CARE HOSPITAL. 
 
The consecutive ST228 outbreaks seen in a Swiss tertiary care hospital (Figure 6) over a ten-
year period represented an opportunity to explore whether phenotypic variations can be 
used to account for outbreaks, after phylogenetic analysis of eight isolates from various years 
showed that the epidemic clones were close relatives, leading to the conclusion that the 
genomic data alone was not sufficient in explaining the markedly increased incidence of 
ST228 in 2008. In an attempt to gain some understanding of the molecular mechanisms that 
might have been responsible for the repeated resurgence of this clone, a “phenotype-first” 
approach to exploring epidemics might give some indication of what drove this clones rapid 
dissemination. 
Biofilm formation, δ toxin and PSM production and phage susceptibility were studied in ST228 
isolates taken throughout the 10-year period of study. Biofilm formation was studied 
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quantitatively (OD595) through crystal-violet staining, the most common method of 
investigating biofilm formation in bacteria (J. Azeredo et al., 2017a). Biofilms play an 
important role in transmission and survival of MRSA, both factors which are essential to 
epidemic behaviour (Vanhommerig et al., 2014). The formation of biofilm matrices afford the 
community of bacteria within added protection against external stressors (including 
antimicrobials), allowing them to persist longer in clinical environments (Lister and Horswill, 
2014), making biofilm formation a phenotype that might have contributed to the Lausanne 
outbreaks. However, the data presented in Figure 8, representing the production of biofilms 
by ST228 isolates taken during the surveillance programme established at the University 
Hospital of Lausanne between 2000 and 2009, showed abnormally low biofilm production in 
all isolates tested. While microtiter plate dye-staining approaches to measure biofilms have 
the advantage of being high-throughput and versatile, a well-known limitation of this 
technique is the experiments lack of reproducibility, accounting for the large degree of error. 
Another limitation of this technique is the frequency with wish biofilm biomass is 
overestimated or underestimated, depending on the washing step (J. Azeredo et al., 2017a). 
This is a likely explanation for the unexpectedly low biofilm biomass seen in Figure 8. The 
dataset is also made poorer by the lack of positive control used during the data collection, 
which may have been used in order to standardise the dataset to account for potential over-
washing of the biofilm.   
PSMs are a family of secreted peptides with multiple functions in staphylococcal 
pathogenesis. PSMs exert their influence over staphylococcal pathogenicity through the 
recruitment and lysis of neutrophils. There are seven PSM genes encoded for by the S. aureus 
core genome, including δ-toxin (Kretschmer et al.), and are putatively regarded as more 
frequently produced in more pathogenic strains of S. aureus (Cheung et al., 2014). The 
operons psmα, psmβ and RNAIII (encoding δ-toxin) are all under the strict control of the the 
AgrA DNA binding protein, with PSMs playing a vital role in biofilm detachment and strain 
dissemination (Periasamy et al., 2012). As a result, production of PSMs was another 
phenotype investigated in order to attempt to gain insights into the molecular processes that 
governed the Lausanne outbreaks. Figure 9 demonstrates, through the use of a lipid vesicle 
lysis assay, that ST228 isolates from both outbreak years and non-outbreak years displayed 
low PSM production, remaining consistent with the avirulent control, DH5α.  This coincides 
with previous work categorising ST228 as a strain that produces low amounts of PSMs 
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(Rasigade et al., 2013).  No difference in PSM production was observed in isolates taken from 
outbreak period when compared against those isolated outside of the epidemics. Thus it 
came be inferred that a change in PSM production is unlikely to be a factor that influenced 
the ST228 outbreaks. 
ST228 isolates taken from outbreak and non-outbreak periods were also tested for their 
susceptibility to lysis by bacteriophage (Figure 11). Phage are now understood to play an 
important role in determining the microbial ecology of an environment, as well as acutely 
influencing microbial evolution (Donlan). Lytic phage complete their life cycle through 
invading and propagating within a bacterial host, mediating competition among strains in the 
process (Meaden and Koskella, 2013). With this in mind, we explored whether there was a 
relationship between the susceptibility of ST228 isolates to two available phage, Dra88 and 
phage K, and the year of isolation. However, no difference in susceptibility to phage lysis was 
observed in any of the isolates examined (Figure 11). This suggests that the elevated 
incidence of cases of infection by ST228 in 2008 was not the result of an evolutionary change 
in phage susceptibility. If this were the case, it would be reasonable to expect the ST228 
isolate from 2009 to grow significantly more in the presence of bacteriophage than the other 
isolates tested. That said, however, no concrete inferences can be made from these data. This 
may be a consequence of either an insufficient number of biological repeat for each year 
carried out or due to the genetic similarity of the two phage used (Alves et al., 2014).  
AIM 3: DETERMINE NOVEL CANDIDATE GENES ASSOCIATED WITH PROTEASE PRODUCTION AND 
BIOFILM FORMATION THROUGH A GENOME-WIDE ASSOCIATION STUDY OF A POPULATION OF 
ST239 
 
ST239 Protease Screening  
S. aureus virulence depends significantly upon the expression of a secretese of proteases, 
including cysteine proteases, staphopains A and B (ScpA and SspB respectively), zinc-
dependent metalloprotease aureolysin (Aur) and several serine proteases (Zdzalik et al., 
2012). These proteases are positively regulated by the action of agr and negatively regulated 
by sarA and play numerous roles, including nutrient acquisition, evasion of host immunity by 
interacting with plasma proteins and antimicrobial peptides (Pietrocola et al., 2017). A screen 
of a population of MRSA-ST239 isolates from four tertiary care hospitals in Turkey using 
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casein agar showed that protease production varied throughout the collection (Figure 13), 
however, when these data were grouping into the types of infections the samples originated 
from, no difference in average protease production was observed (Figure 14). A number of 
loci with a potential association with protease production were found to be within mobile 
genetic elements known as SaPIs, superantigen pathogenicity islands. The SaPIs are mobile 
phage-related pathogenicity islands that often harbour at least one superantigen gene 
(Alibayov et al., 2014). The high association between SNPs in genes within SaPIs and changes 
in protease activity may be expected, since it has been documented that the expression of 
superantigens, particularly TSST-1, pleiotropically represses the expression of the major 
protease gene sspA (V8 protease) (Calander et al., 2008). While the study of these loci was 
omitted from this study in the interest of time, future analysis of these loci and their 
relationship to proteolysis in S. aureus may well be warranted. 
Select transposon mutants with transposon insertions in genes affected by SNPs shown to 
have a potential association with a change in protease activity resulted in a decrease in 
protease activity, except agrC, where inactivating the locus through the insertion of a 
transposon had a negligible effect on general protease production in USA300_FPR3757. 
SAUSA300_2494 (a copper-translocating P-type ATPase encoding gene) and SAUSA300_1728 
(an oxidoreductase, aldo/keto reductase family protein encoding gene) had the smallest 
decrease in protease activity when compared to JE2 (the USA300_FPR3757 reference strain), 
whilst murA had the largest decrease in protease activity (Figure 14).  
The agr system facilitates the detachment of biofilms through its interference with protease 
expression. AgrC is a membrane protein that binds to autoinducing peptide (AIP), a quorum 
sensing molecule secreted during growth and responsible for activating gene expression in a 
cell density dependent manner (Olson et al., 2014). Increasing levels of exogenous AIP, 
detected through AgrC, functions as a biofilm detachment signal. This activates the agr 
system and leads to the upregulation of extracellular proteases, which work to degrade the 
biofilm and signals a switch into a planktonic state (Boles and Horswill, 2008). As a result, the 
interruption of the agrC gene by the transposon insertion having a negligible effect on 
protease production is surprising.  
This departure from the anticipated effect of an agr knockout may call into question the 
reliability of the data collected. The method used to assess protease production involved the 
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manual measuring of the wide of the zone of clearance, made through casein cleavage by 
common extracellular proteases had a clear limitation – measurements were made by eye 
with a ruler in order to provide a quantitative measurement for protease activity. While every 
effort was made to ensure the consistency and accuracy of the measurements, a more robust 
assay to screen protease production may have resulted in a clearer dataset.  
That said, however, the fact that the protease data for the ST239 cohort shows a strong 
negative correlation against δ -toxin production (Figure 16) might actually validate that the 
milk plate assay was sufficient in measuring protease activity. Many master regulators 
(including the agr operon and the sarA system) regulate both protease activity and toxin 
production (Bronner, Monteil and Prévost, 2004). However, the exact regulators involved are 
not clear. For example, the agr system is well known as an important upregulator of toxins (δ 
toxin itself for instance, one of the toxins assayed through the vesicle lysis test, is a 
component of RNAIII, a direct transcriptional product of the agr operon), however it has also 
been shown that the agr system upregulates aur, ssp and scp, three important protease 
genes (Shaw et al., 2004). That said however, sarA has been described as a potent 
downregulator of protease gene expression (Bronner, Monteil and Prévost, 2004) and, in the 
case of PSMs, the downregulation of the protease aureolysin in particular reduces post-
secretion degradation of PSMs (Rasigade et al., 2013), which may account for the negative 
correlation between the two phenotypes. Further comprehensive analysis of the potential 
regulators of ST239 is warranted to elucidate the true regulatory systems that govern this 
inverse correlation between protease production and toxicity.  
During the project, an attempt was made at developing a microtiter plate assay, measuring 
proteolytic activity in a sample through optical density readings made after a colormetric test. 
The proposed assay, modified from (Cupp-Enyard, 2008),  aimed to measure the degradation 
of casein through the reaction between liberated tyrosine and Folin and Ciocalteus Phenol 
reagent, a reaction which produces a blue-coloured chromophore (Cupp-Enyard, 2008), 
however, the optimization of this assay for bacterial supernatants was not completed during 
the project. That said, another potential reason for the lack of conclusive data regarding the 
protease production of the transposon mutants could be a difference between how 
proteolytic the USA300_ FPR3757 background is compared to ST239. Further testing, 
however, would be required to qualify this. 
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ST239 Biofilm Formation Screening 
Biofilm formation is an important clinical phenotype: responsible for over 60% of microbial 
infections, and 80% of chronic infections (Gutiérrez et al., 2017). Through a modified version 
of crystal violet staining assay with fewer wash steps, biofilm formation of the ST239 
collection was quantified (Figure 19). Transposon knockouts for candidate loci with the 
potential of having an association with biofilm formation were isolated, and compliments for 
5 of these candidate genes were produced.  
These genes are as followed: mecA (carried within SCCmec) which encodes the penicillin-
binding protein PBP2a (Wielders et al., 2002)); ccrB, also carried on the SCCmec element, 
encodes a site-specific recombinase that putatively mediates both the integration and 
excision of SCCmec into/out of the staphylococcal core genome (Wang and Archer, 2010); 
sgaT, a transmembranous putative part of the phosphoenolpyruvate-dependent sugar 
phosphotransferase system (PTS); app, an uncharacterized amino acid permease and hyp, an 
uncharacterized hypothetical protein. 
The apparent association between the SCCmec element and biofilm formation is not a novel 
one, with significantly higher rates of biofilm development in strains with greater antibiotic 
resistance having been previously reported, dispelling the previous assumption that increased 
levels of antibiotic resistance in “biofilm-positive” MRSA can wholly be attributed to the 
biofilm acting as a physical barrier against the action of antibiotics (Kwon et al., 2008; Reiter 
Keli et al., 2011). In ica-independent biofilm formation (the ica locus having been shown to be 
redundant for MRSA biofilm formation (O'Neill et al., 2007)), the action of PBP2a (produced 
by mecA, thus also involving ccrB) represses the agr system which, as a result, downregulates 
the production of PSMs, proteases and virulence determinants. PBP2a concurrently also 
upregulates biofilm-production, due to the putative down regulation of agr, thus inhibiting 
the agr-mediated upregulation of the proteases responsible for biofilm dispersal (McCarthy et 
al., 2015). 
Phosphotransferase system (PTS) transporters are the predominant class of bacterial 
carbohydrate transporters, which are responsible for importing exogenous sugars into the cell 
as well as modifying the sugars during their transport through the membrane. Glucose has 
been previously described as a substrate capable of influencing the expression of S. aureus 
virulence factors. Biofilm-related genes cidA and icaA are upregulated in the presence of 
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exogenous glucose, alongside the glucose-mediated downregulation of the agr system (Vitko 
et al., 2016). 
Mature S. aureus biofilms maintain a dynamic flux of metabolic activity, uptaking and 
excreting both carbon and amino acid regularly (Zhu et al., 2007). Branched-chain amino acids 
(BCAAs) are particularly required for cell growth, S. aureus being auxotrophic for leucine and 
valine. Depletion of BCAAs results in the downregulation of CodY, a global transcriptional 
regulator involved in a range of cellular processes, including biofilm formation (Kaiser et al., 
2015). Amino acid permeases, such as the putative amino acid permease gene studied here, 
are membrane permeases that transport amino acids into the cell. It is clear that amino acid 
metabolism plays some role in the establishment of biofilms, however further work into the 
number of amino acid permeases that remain uncharacterised would certainly be warranted 
(Zhu et al., 2007). 
Finally, the hypothetical protein studied in this section, while uncharacterized, encoded the 
hypothetical protein YP_494229.1, matching a protein family HMM PF01957 (Coordinators, 
2016) , an NfeD-like protein, a gene frequently associated with genes encoding stomatin-like 
proteins (or slipins) (Green, Lower and Young, 2009). This is a widely expressed mitochondrial 
inner membrane protein, putatively thought to regulate mitochondrial biogenesis and 
function (Christie et al., 2011). Another interesting avenue for future work would be to 
further elucidate the role of this and other genes expressing stomatin-like proteins. 
However, when these complemented strains were tested for biofilm formation alongside 
their transposon mutant counterparts, no significant difference was observed (Figure 19). This 
may be due to the high degree of error in the crystal violet assay, given the assays tendency 
for the biofilm to be disrupted by the washing steps, an explanation that aligns with the fact 
that transposon mutants and the JE2 wild type are comparable biofilm producers in this 
dataset (Figure 19). Given more time, repeating the complementation assay would, in part, 




In the first of the three projects that make up this body of work, an attempt was made at 
applying metagenomic principles to the unique situation of a ward relocation. However, the 
microbial diversity recovered from glycerol stocks displayed markedly different population 
dynamics to what would be expected in clinical environmental swabs. Selective agar 
screening revealed the extent to which the selective media used was inappropriate for a 
metagenomic study, with Pseudomonas spp. having been recovered substantially less 
frequency than expected, with Enterococci almost ubiquitously producing lawns from glycerol 
stocks from which very little/no Pseudomonas spp. or Staphylococcus spp. were isolated from. 
This serves as a cautionary tale of the importance of comprehensive experimental design, 
particularly prior to time-sensitive projects. 
 
To investigate the efficacy of approaching nosocomial outbreaks from a phenotype-first 
prospective (with a view toward elucidating potential new candidate genes capable of playing 
a role in epidemics), a cohort of 207 MRSA-ST228 isolates (also known as the South German 
Epidemic strain or the Italian clone); a multiple-antibiotic resistant, gentamicin resistant 
SCCmec-I strain of MRSA from CC5 (Mendes et al., 2012), responsible for a temporally 
isolated outbreak in a Swiss hospital in 2008. Subsets of this cohort were screened for 
changes in several important phenotypes in HA-MRSA colonisation, dispersal and virulence, 
including biofilm formation, PSM and α-toxin production and bacteriophage susceptibility. It 
is hoped that any changes of these phenotypes of samples that were isolated during outbreak 
periods can be used to highlight potential candidate phenotypes that contributed to the 
sudden outbreak.  
 
The second collection studied was a cohort of MRSA -ST239, a globally dispersed and highly 
persistent ST; a hybrid of descendants of two major lineages, CC8 and CC30, deemed 
responsible for numerous epidemics in healthcare environments worldwide (Smyth et al., 
2010), accounting for over 90% of HA-MRSA in China, Turkey, Thailand and much mainland 
Asia (Lahiri et al., 2015). Regarding the global ST239, the collection used was of 95 Turkish 
isolates taken since, given the countries placement between Europe and Asia, this collection 
provided previously published insights into the spread of this clone outside Europe (Smyth et 
al., 2010). Given promising inferences gained from this already fully sequenced collection in 
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terms of toxin and adhesion production (M. Laabei et al., 2014b), biofilm and protease 
production (phenotypes that have yet to be studied in this collection) were analysed and 
potentially significant associations between phenotype and certain candidate SNPs were 
established. After screening both biofilm production and protease activity of the ST239 
cohort, a top down GWAS approach was then be carried out in an attempt to elucidate the 
genes involved. However, the data gathered for protease activity suffered either from 
intrinsic limitations to the sensitivity of the method used, or due to inherent wild type 
differences in protease production between ST239 and the USA300_FPR3757 backgrounds. 
The study of ST239 biofilm formation identified five candidate genes associated with biofilm 
formation (mecA, sgaT, ccrB, aap and hyp). However, in the complementation analysis that 
followed, the transposon mutants used were unaccountably no different in their ability to 
produce biofilms than the JE2 wild type, suggesting that this experiment requires repeating 
for meaningful conclusions to be gleaned. 
Medical microbiology has made substantial gains as a direct consequence of the introduction 
of next-generation sequencing technologies in the 2000s, with whole genome sequencing 
playing critical roles in epidemiology, detecting virulence factors and studying antibiotic 
resistance within pathogenic species (Padmanabhan et al., 2013). The post-genomic era holds 
great promise, with further advances in genomic technologies heralded as a vital step 
towards solving some of our most urgent medical challenges. 
FUTURE WORK 
Aim 1: Survey changes to the microbial burden of a burns unit caused by its re-location  
The task of monitoring the environmental microbial load of the Bristol paediatric burns unit 
was a time-sensitive project and, unfortunately, the samples collected did not reflect the true 
diversity of the microbiome of either the ward environment or clinical staff.  However, should 
another opportunity arise in which a long-established clinical environment moves 
geographically, the shotgun metagenomic screening of fomites, fixed surfaces and clinical 
staff pre- and post-relocation is still of great benefit. As our results demonstrate, careful 
consideration is needed when determining how samples intended for use in metagenomic 
surveys are collected and prepared. While sampling and sample preparation vary widely in 
metagenomic studies, a number of common factors are important when considering 
experimental design. For instance, if large amounts of host DNA can be expected in sample, 
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fractionation or selective lysis may be necessary to ensure that the microbial sequences are 
not overwhelmed (Thomas, Gilbert and Meyer, 2012a). Additionally, in instances where 
swabs be used in sample collection, as it was in this project, low yield of DNA may also be a 
challenge. Since library production for most sequencers require micrograms of DNA, 
amplification of DNA material extracted from the samples may require amplification through, 
for instance multiple displacement amplification (MDA) (Thomas, Gilbert and Meyer, 2012a). 
From there, the subsequent DNA sequencing, annotation, statistical analysis and metadata 
analysis of clinical samples can be carried out. 
While, in the case of the Bristol burns ward, the scope of the investigation was limited to 
coagulase negative and coagulase positive staphylococci, a broader metagenomic study of 
any clinical environment that encompasses a wider range of organisms (for instance, the 
ESKAPE pathogens) might also yield some insights into the transmission of nosocomial 
pathogens that can then be used to inform, and potentially reform, current infection control 
practices. 
Aim 2: Survey changes to the microbial burden of a burns unit caused by its re-location  
While the project studying ST228 isolates from Lausanne Hospital did not yield any significant 
results, there were a number of experimental flaws that may have led to this. For instance, 
further study of the variation of biofilm formation for the entire strain collection with 
sufficient biological and experimental repeats is warranted, especially if a crystal violet 
staining assay is used to quantify biofilm development, given the variability of the assay. 
Indeed, testing the entire collection for all the phenotypes studied would be of great benefit. 
Additionally, only two very closely related phage were used to test bacteriophage resistance. 
Given the abundance and variety of bacteriophage, a survey of this scale cannot be used to 
determine whether resistance to bacteriophage was associated with the outbreak. Further 
study of this collections resilience against a variety of distantly related bacteriophage would 
be necessary to draw any meaningful conclusions.  
It might also be interesting to explore the action of any small RNA molecules or RNA-RNA 
interactions at a post-transcriptional level that might be associated with the outbreak. RNA 
mediated changes in for these strains could be quantified via reverse transcription PCR (RT-
PCR) in different in vitro conditions. Additionally, protease production, through an assay 
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similar to the one presented in Chapter 3, alongside surveying other phenotypes, such as 
fibrinogen-binding and fibronectin-binding (Stemberk et al., 2014) 
Aim 3: Determining novel candidate genes associated with protease production and biofilm 
formation through a GWAS of a population of ST239  
A high-throughput solution to the quantification of exogenous proteases from bacterial 
supernatant was developed during this project. While the milk agar assay used here was 
helpful in determining qualitatively which isolates showed unusually high biofilms, 
measurements were prone to human error. A protease assay suitable for bacterial 
supernatant that is both high-throughput and accurate would be ideal in scenarios such as 
this. An example of how this might be achieved could be through measuring amino acids 
liberated by protease activity with chemical reagents that undergo a colormetric change in 
the presence of particular amino acids, such as Folin reagent, as was attempted here. While in 
this instance the source of the unreliability of the data produced could not be determined, 
adequate troubleshooting in future attempts might lead to a more efficient way of studying 
protease production. 
Five candidate genes were found to be potentially associated with biofilm production in the 
ST239 dataset, mecA, ccrB, sgaT, aap and hyp. While the cloning required for 
complementation was thought to be successful, this step may need to be repeated before the 
relevance of these loci is discounted. If any genes, after complementation, still seem likely to 
have a true association with biofilm formation, protein purification and characterisation of 
the proteins encoded by these genes in the best and worst biofilm forming isolates of this 
cohort would be of benefit. This may include simple assays such as western blotting, or 
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Appendix 1 – Primers designed from complementation of biofilm associated candidate genes 





ccrB Forward GGCTGCGAATTCCGAGGAGATTGTAAGATG EcoRI 
817 
ccrB Reverse GTCGGCGGTACCAATACGATGGACTCGGTG KpnI 
sgaT Forward CGTTTCGAATTCAAGGAGGTTCGACCTATG EcoRI 
1575 
sgaT Reverse CCCGAGGGTACCGGCATTCACTCAATATGTGAC KpnI 
aap Forward TGCCCAGAATTCAACGAAGGAGTATTTATG EcoRI 
2099 
aap Reverse GCCGAGGGTACCCATTGATTTATGTCCCAGCC KpnI 
hyp Forward GGCTTTGAATTCCTAAACATGGTATCGCTCC EcoRI 
948 
hyp Reverse GCAGACGGTACCTACCTCTGTTGACTCCCTC KpnI 
mecA Forward CTCAAGGAATTCAGGAGGATATTGATG EcoRI 
2155 
mecA Reverse GATCCGGGTACCGTGAAGCAACCATCGTTACGG KpnI 
 
     
Appendix 2 - Environmental strains collected from Frenchay Hospital Barbara Russell 
Children’s burns unit (Before move) 
Room collected from Items swabbed 
Growth after initial 
plating on TSA Sample reference 
Burns clinic (room 3) Cupboard handles Many small colonies BRCU1-CH1 
Burns assessment room Cupboard handles Few small colonies BRCU1-CH2 
Dressing changing room Cupboard handles Many large colonies BRCU1-CH3 
Burns assessment room Touch screen monitors Many small colonies BRCU1-TSM1 
Burns reception Touch screen monitors Lawn BRCU1-TSM2 
HDU reception Touch screen monitors Lawn BRCU1-TSM4 
Burns clinic (room 3) Computer monitors Mixed lawn BRCU1-CM1 
Burns assessment room Computer monitors Many small colonies BRCU1-CM2 
Burns reception Computer monitors Few large colonies BRCU1-CM4 
Burns clinic (room 3) Keyboards and mouse Lawn BRCU1-K1 
Burns assessment room Keyboards and mouse Mixed lawn BRCU1-K2 
Mobile laptop Keyboards and mouse Lawn BRCU1-K3 
Burns reception Keyboards and mouse Mixed lawn BRCU1-K4 
Nurse station 1 Keyboards and mouse Many small colonies BRCU1-K5 
Nurse station 2 Keyboards and mouse Mixed lawn BRCU1-K6 
Starfish ward (TV) Remote controls Lawn BRCU1-R1 
Burns assessment room Remote controls Lawn BRCU1-R2 
Playroom (TV) Remote controls Few large colonies BRCU1-R4 
Burns clinic (room 3) Tap/Shower head Lawn BRCU1-TH1 
91 
Burns bathroom sink Tap/Shower head Lawn BRCU1-TH3 
Burns bathroom shower Tap/Shower head Lawn BRCU1-TH4 
Burns bathroom sink Sinks Mixed lawn BRCU1-S3 
Burns bathroom bath Sinks Few large colonies BRCU1-S4 
Burns room 2 Sinks Lawn BRCU1-S5 
Burns room 2 Bed linen Many small colonies BRCU1-BL2 
Burns room 3 Bed linen Lawn BRCU1-BL4 
Physiotherapy room Bed linen Lawn BRCU1-BL5 
Burns clinic (room 3) Bed posts Few small colonies BRCU1-BP1 
Starfish ward  Bed posts Mixed lawn BRCU1-BP4 
Burns clinic (room 1) Bed posts Lawn BRCU1-BP6 
Physiotherapy room Bike handles Mixed lawn BRCU1-PT1 
Physiotherapy room Large exercise ball Many large colonies BRCU1-PT4 
Physiotherapy room Balance beam Lawn BRCU1-PT5 
Playroom Book (Grunter) Mixed lawn BRCU1-Book3 
Corridor Book (Ex Files) Mixed lawn BRCU1-Book4 
Corridor Magazine (Marie Claire) Mixed lawn BRCU1-Book5 
Burns clinic (room 3) Toy (Car) Mixed lawn BRCU1-Toy1 
Burns assessment room Toy (Small ball) Lawn BRCU1-Toy2 
Burns bathroom Toy (Boat) Many large colonies BRCU1-Toy3 
Playroom Toy (Kitchen) Lawn BRCU1-Toy4 
Playroom Toy (Castle) Lawn BRCU1-Toy5 
School 
Touch screen tablets 
(Black) Lawn BRCU1-TST1 
Playroom 
Touch screen tablets 
(Anti-microbial case) Lawn BRCU1-TST2 
Playroom 
Touch screen tablets (No 
case) Many large colonies BRCU1-TST3 
School 
Touch screen tablets 
(Red) Lawn BRCU1-TST4 
Nurses station 2 Office desk Mixed lawn BRCU1-D3 
Main desk Office desk Mixed lawn BRCU1-D4 
Burns clinic main desk Office desk Mixed lawn BRCU1-D5 
Burns assessment room Worktop Lawn BRCU1-W1 
Dressing changing room Worktop Many small colonies BRCU1-W2 
HDU reception Worktop Mixed lawn BRCU1-W3 
School Worktop Mixed lawn BRCU1-W4 
Burns clinic staff room Worktop Mixed lawn BRCU1-W5 
Burns clinic (room 1) Worktop Many small colonies BRCU1-W6 
HDU reception Play surfaces Many small colonies BRCU1-P1 
Playroom Play surfaces Mixed lawn BRCU1-P2 
Corridor Play surfaces Lawn BRCU1-P3 
Sensory room Play surfaces Mixed lawn BRCU1-P4 
Waiting area Play surfaces Mixed lawn BRCU1-P5 
92 
School Play surfaces Lawn BRCU1-P6 
Burns clinic (room 3) Door handles Many small colonies BRCU1-DH1 
Burns bathroom Door handles Many small colonies BRCU1-DH3 
Burns room (2) Door handles Many large colonies BRCU1-DH4 
Burns clinic (room 3) Phones Mixed lawn BRCU1-Phn1 
Burns assessment room Phones Mixed lawn BRCU1-Phn2 
Burns main desk Phones Mixed lawn BRCU1-Phn3 
Nurses station 1 Phones Lawn BRCU1-Phn4 
Burns clinic staff room Phones Lawn BRCU1-Phn5 
Burns clinic main desk Phones Mixed lawn BRCU1-Phn6 
 
Appendix 3 - Strains collected from Frenchay Hospital Barbara Russell Children’s burns unit 





Growth after initial 
plating on TSA 
Sample 
reference 
Nurse Hand  BS1 Lawn N1H 
Nurse Nose BS1 Many colonies N1N 
Nurse ID card BS1 Many colonies N1C 
Nurse Hand  BS16 Lawn N2H 
Nurse Nose BS16 Many colonies N2N 
Nurse ID card BS16 Many colonies N2C 
Nurse Hand  Not given Lawn N4H 
Nurse Nose Not given Lawn N4N 
Nurse ID card Not given Lawn N4C 
Nurse Hand  Not given Lawn N5H 
Nurse Nose Not given Lawn N5N 
Nurse ID card Not given Lawn N5C 
Nurse Hand  BS15 Many colonies N6H 
Nurse Nose BS15 Lawn N6N 
Nurse ID card BS15 Lawn N6C 
Nurse Hand  BS35 Lawn N7H 
Nurse Nose BS35 Few colonies N7N 
Nurse ID card BS35 Lawn N7C 
Nurse Hand  BS36 Lawn N8H 
Nurse Nose BS36 Lawn N8N 
Nurse ID card BS36 Lawn N8C 
Nurse Hand  BS36 Many colonies N9H 
Nurse Nose BS36 Lawn N9N 
Nurse ID card BS36 Lawn N9C 
Nurse Hand  BS10 Lawn N10H 
Nurse Nose BS10 Lawn N10N 
Nurse ID card BS10 Few colonies N10C 
93 
Doctor Nose BS9 Lawn D2N 
Doctor Hand  BS39 Lawn D3H 
Doctor Nose BS39 Lawn D3N 
Doctor Hand  BS36 Lawn D7H 
Doctor Nose BS36 Lawn D7N 
Doctor ID card BS36 Lawn D7C 
Doctor Hand  BS6 Lawn D8H 
Doctor Nose BS6 Lawn D8N 
Doctor ID card BS6 Lawn D8C 
Doctor Hand  Not given Lawn D9H 
Doctor Nose Not given Many colonies D9N 
Doctor ID card Not given Many colonies D9C 
Miscellaneous 
staff Hand  GL12 Lawn H1H 
Miscellaneous 
staff Nose GL12 Few colonies H1N 
Miscellaneous 
staff ID card GL12 Few colonies H1C 
Miscellaneous 
staff Hand  BS16 Lawn H3H 
Miscellaneous 
staff Nose BS16 Lawn H3N 
Miscellaneous 
staff ID card BS16 Lawn H3C 
Miscellaneous 
staff Hand  BS16 Lawn H7H 
Miscellaneous 
staff Nose BS16 Lawn H7N 
Miscellaneous 
staff ID card BS16 2 colonies only H7C 
Miscellaneous 
staff Hand  BS8 Lawn H8H 
Miscellaneous 
staff Nose BS8 Lawn H8N 
Miscellaneous 
staff ID card BS8 Lawn H8C 
 
Appendix 4 - Strains collected from the new  location for the Bristol Children’s burns unit, 
Bristol Royal Hospital for Children (Before the move) 
Items swabbed Room 
Sample 
reference 
Sink handle Treatment room TR1 
Inside tap nossle Treatment room TR2 
Sink basin Treatment room TR3 
Worktop Treatment room TR4 
94 
Green cupboard Treatment room TR5 
Door handles Treatment room TR6 
Sink handle Large room LR1 
Inside tap nossle Large room LR2 
Sink basin Large room LR3 
Shower tap Large room LR4 
Window ledge Large room LR5 
Power switches Large room LR6 
Sink handle Media room 1 MR1 
Sink basin Media room 1 MR2 
Power swiitches Media room 1 MR3 
Cupboard handles Media room 1 MR4 
Bath Bathroom BTL1 
Bath buttons/dials Bathroom BTL2 
Shower Bathroom BTL3 
Nappy changing unit Bathroom BTL4 
Sink handle Bathroom BTL5 
Sink basin Bathroom BTL6 
Desk Reception RP1 
Desk Reception RP2 
Phone Reception RP3 
 
Appendix 5- Strains collected from a surgical suite before and after a surgical procedure, as 
well as after cleaning through “fogging” within the new location for the Bristol Children’s 
burns unit, Bristol Royal Hospital for Children (After move) 
Items swabbed Room Tine of swabbing Sample reference 
Theatre trolley top (metal) Burns theatre Before surgery BT2 
Theatre trolley top (metal) Burns theatre Before surgery BT3 
Patient arm 'L' boards Burns theatre Before surgery BT6 
In theatre computer keyboard and 
mouse Burns theatre Before surgery BT7 
In theatre computer monitor screen Burns theatre Before surgery BT8 
In theatre computer fan grill Burns theatre Before surgery BT9 
Scrubbing up bench Burns theatre Before surgery BT11 
Operating table bolster cushions Burns theatre Before surgery BT16 
In theatre dressing trolley handle Burns theatre Before surgery BT19 
Tourniquet cuffs Burns theatre Before surgery BT20 
Patient arm 'L' boards Burns theatre After surgery AT3 
Anaesthetic machine buttons Burns theatre After surgery AT5 
Patient arm 'L' boards Burns theatre After surgery AT6 
In theatre computer keyboard and 
mouse Burns theatre After surgery AT7 
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In theatre computer fan grill Burns theatre After surgery AT9 
Scrubbing up bench Burns theatre After surgery AT11 
Scrub sink tap handles Burns theatre After surgery AT13 
In theatre dressing trolley top Burns theatre After surgery AT18 
In theatre dressing trolley handle Burns theatre After surgery AT19 
Tourniquet cuffs Burns theatre After surgery AT20 
Diathermy machine buttons  Burns theatre After fogging F10 
Scrubbing up bench Burns theatre After fogging F11 
In theatre trolley top  Burns theatre After fogging F18 
In theatre trolley handles  Burns theatre After fogging F19 
Bench top 
Anaesthetic 
room Before surgery  BA1 
Room telephone 
Anaesthetic 
room Before surgery  BA2 
Cupboard handles 
Anaesthetic 
room Before surgery  BA3 
Sink tap handle 
Anaesthetic 
room Before surgery  BA4 
Sink plug hole 
Anaesthetic 
room Before surgery  BA5 
Sink tap nozzle 
Anaesthetic 
room Before surgery  BA6 
Anaesthetic machine buttons 
Anaesthetic 
room Before surgery  BA7 
Sink plug hole Recovery room Before surgery BR2 
Sink tap Recovery room Before surgery BR3 
Computer keyboard/mouse Recovery room Before surgery BR4 
Computer screen Recovery room Before surgery BR5 
Computer fan grill Recovery room Before surgery BR6 
 
 
